BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 1451621 Cn1ncc(c1-c1ccc(OCc2cc(C(O)=O)c3ccccc3n2)cc1)-c1ccncc1 InChI=1S/C26H20N4O3/c1-30-25(23(15-28-30)17-10-12-27-13-11-17)18-6-8-20(9-7-18)33-16-19-14-22(26(31)32)21-4-2-3-5-24(21)29-19/h2-15H,16H2,1H3,(H,31,32) VCWJVDKPTJNBTE-UHFFFAOYSA-N 700213 2-[[4-[2-Methyl-4-(4-pyridyl)pyrazol-3-yl]phenoxy]methyl]quinoline-4-carboxylic acid::US20240336591, Example 1 cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A isoform 2 Homo sapiens 0.372 US Patent 10.7270/Q29G5S87 aid2060456 US20240336591 PATIENT, L; ALMOND-THYNNE, J; UNSWORTH, PJ; YIP, AC; ROBAS, N; BELICH, MP 10/10/2024 2/10/2025 Benevolentai Cambridge http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=700213 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8174&target=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A+isoform+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=700213&enzyme=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A+isoform+2&column=ki&startPg=0&Increment=50&submit=Search 167444496 505949283 1 MEDGPSNNASCFRRLTECFLSPSLTDEKVKAYLSLHPQVLDEFVSESVSAETVEKWLKRKNNKSEDESAPKEVSRYQDTNMQGVVYELNSYIEQRLDTGGDNQLLLYELSSIIKIATKADGFALYFLGECNNSLCIFTPPGIKEGKPRLIPAGPITQGTTVSAYVAKSRKTLLVEDILGDERFPRGTGLESGTRIQSVLCLPIVTAIGDLIGILELYRHWGKEAFCLSHQEVATANLAWASVAIHQVQVCRGLAKQTELNDFLLDVSKTYFDNIVAIDSLLEHIMIYAKNLVNADRCALFQVDHKNKELYSDLFDIGEEKEGKPVFKKTKEIRFSIEKGIAGQVARTGEVLNIPDAYADPRFNREVDLYTGYTTRNILCMPIVSRGSVIGVVQMVNKISGSAFSKTDENNFKMFAVFCALALHCANMYHRIRHSECIYRVTMEKLSYHSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED 4DFF,6IJH,4AEL,2WEY,5SKV,5SKU,5SKT,5SKS,5SKR,5SKQ,5SKP,5SKO,5SKN,5SKM,5SKL,5SKK,5SKJ,5SKI,5SKH,5SKG,5SKF,5SKE,5SKD,5SKC,5SKB,5SKA,5SK9,5SK8,5SK7,5SK6,5SK5,5SK4,5SK3,5SK2,5SK1,5SK0,5SJZ,5SJY,5SJX,5SJW,5SJV,5SJU,5SJT,5SJS,5SJR,5SJQ,5SJP,5SJO,5SJN,5SJM,5SJL,5SJK,5SJJ,5SJI,5SJH,5SJG,5SJF,5SJE,5SJD,5SJC,5SJB,5SJA,5SJ9,5SJ8,5SJ7,5SJ6,5SJ5,5SJ4,5SJ3,5SJ2,5SJ1,5SJ0,5SIZ,5SIY,5SIX,5SIW,5SIV,5SIU,5SIT,5SIS,5SIR,5SIQ,5SIP,5SIO,5SIN,5SIM,5SIL,5SIK,5SIJ,5SII,5SIH,5SIG,5SIF,5SIE,5SID,5SIB,5SIA,5SI9,5SI8,5SI7,5SI6,5SI5,5SI4,5SI3,5SI2,5SI1,5SI0,5SHZ,5SHY,5SHX,5SHW,5SHV,5SHU,5SHT,5SHS,5SHR,5SHQ,5SHP,5SHO,5SHN,5SHM,5SHL cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A PDE10_HUMAN Q9Y233 A0A3F2YP58 Q6FHX1 Q9HCP9 Q9NTV4 Q9ULW9 Q9Y5T1 1451622 Cn1ncc(c1-c1ccc(OCc2nc3ccccc3cc2C(O)=O)cc1)-c1ccncc1 InChI=1S/C26H20N4O3/c1-30-25(22(15-28-30)17-10-12-27-13-11-17)18-6-8-20(9-7-18)33-16-24-21(26(31)32)14-19-4-2-3-5-23(19)29-24/h2-15H,16H2,1H3,(H,31,32) BGOZEMAHSMAILE-UHFFFAOYSA-N 700214 2-[[4-[2-Methyl-4-(4-pyridyl)pyrazol-3-yl]phenoxy]methyl]quinoline-3-carboxylic acid::US20240336591, Example 2 cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A isoform 2 Homo sapiens 0.204 US Patent 10.7270/Q29G5S87 aid2060456 US20240336591 PATIENT, L; ALMOND-THYNNE, J; UNSWORTH, PJ; YIP, AC; ROBAS, N; BELICH, MP 10/10/2024 2/10/2025 Benevolentai Cambridge http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=700214 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8174&target=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A+isoform+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=700214&enzyme=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A+isoform+2&column=ki&startPg=0&Increment=50&submit=Search 167444612 505949284 1 MEDGPSNNASCFRRLTECFLSPSLTDEKVKAYLSLHPQVLDEFVSESVSAETVEKWLKRKNNKSEDESAPKEVSRYQDTNMQGVVYELNSYIEQRLDTGGDNQLLLYELSSIIKIATKADGFALYFLGECNNSLCIFTPPGIKEGKPRLIPAGPITQGTTVSAYVAKSRKTLLVEDILGDERFPRGTGLESGTRIQSVLCLPIVTAIGDLIGILELYRHWGKEAFCLSHQEVATANLAWASVAIHQVQVCRGLAKQTELNDFLLDVSKTYFDNIVAIDSLLEHIMIYAKNLVNADRCALFQVDHKNKELYSDLFDIGEEKEGKPVFKKTKEIRFSIEKGIAGQVARTGEVLNIPDAYADPRFNREVDLYTGYTTRNILCMPIVSRGSVIGVVQMVNKISGSAFSKTDENNFKMFAVFCALALHCANMYHRIRHSECIYRVTMEKLSYHSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED 4DFF,6IJH,4AEL,2WEY,5SKV,5SKU,5SKT,5SKS,5SKR,5SKQ,5SKP,5SKO,5SKN,5SKM,5SKL,5SKK,5SKJ,5SKI,5SKH,5SKG,5SKF,5SKE,5SKD,5SKC,5SKB,5SKA,5SK9,5SK8,5SK7,5SK6,5SK5,5SK4,5SK3,5SK2,5SK1,5SK0,5SJZ,5SJY,5SJX,5SJW,5SJV,5SJU,5SJT,5SJS,5SJR,5SJQ,5SJP,5SJO,5SJN,5SJM,5SJL,5SJK,5SJJ,5SJI,5SJH,5SJG,5SJF,5SJE,5SJD,5SJC,5SJB,5SJA,5SJ9,5SJ8,5SJ7,5SJ6,5SJ5,5SJ4,5SJ3,5SJ2,5SJ1,5SJ0,5SIZ,5SIY,5SIX,5SIW,5SIV,5SIU,5SIT,5SIS,5SIR,5SIQ,5SIP,5SIO,5SIN,5SIM,5SIL,5SIK,5SIJ,5SII,5SIH,5SIG,5SIF,5SIE,5SID,5SIB,5SIA,5SI9,5SI8,5SI7,5SI6,5SI5,5SI4,5SI3,5SI2,5SI1,5SI0,5SHZ,5SHY,5SHX,5SHW,5SHV,5SHU,5SHT,5SHS,5SHR,5SHQ,5SHP,5SHO,5SHN,5SHM,5SHL cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A PDE10_HUMAN Q9Y233 A0A3F2YP58 Q6FHX1 Q9HCP9 Q9NTV4 Q9ULW9 Q9Y5T1 1451623 Cn1cc(c(n1)-c1ccc(OCc2nc3ccccc3cc2C(O)=O)cc1)-c1ccncc1 InChI=1S/C26H20N4O3/c1-30-15-22(17-10-12-27-13-11-17)25(29-30)18-6-8-20(9-7-18)33-16-24-21(26(31)32)14-19-4-2-3-5-23(19)28-24/h2-15H,16H2,1H3,(H,31,32) JSQBTTDSSQVZQB-UHFFFAOYSA-N 700215 2-[[4-[1-Methyl-4-(4-pyridyl)pyrazol-3-yl]phenoxy]methyl]quinoline-3-carboxylic acid::US20240336591, Example 3 cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A isoform 2 Homo sapiens 0.079 US Patent 10.7270/Q29G5S87 aid2060456 US20240336591 PATIENT, L; ALMOND-THYNNE, J; UNSWORTH, PJ; YIP, AC; ROBAS, N; BELICH, MP 10/10/2024 2/10/2025 Benevolentai Cambridge http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=700215 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8174&target=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A+isoform+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=700215&enzyme=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A+isoform+2&column=ki&startPg=0&Increment=50&submit=Search 167444586 505949285 1 MEDGPSNNASCFRRLTECFLSPSLTDEKVKAYLSLHPQVLDEFVSESVSAETVEKWLKRKNNKSEDESAPKEVSRYQDTNMQGVVYELNSYIEQRLDTGGDNQLLLYELSSIIKIATKADGFALYFLGECNNSLCIFTPPGIKEGKPRLIPAGPITQGTTVSAYVAKSRKTLLVEDILGDERFPRGTGLESGTRIQSVLCLPIVTAIGDLIGILELYRHWGKEAFCLSHQEVATANLAWASVAIHQVQVCRGLAKQTELNDFLLDVSKTYFDNIVAIDSLLEHIMIYAKNLVNADRCALFQVDHKNKELYSDLFDIGEEKEGKPVFKKTKEIRFSIEKGIAGQVARTGEVLNIPDAYADPRFNREVDLYTGYTTRNILCMPIVSRGSVIGVVQMVNKISGSAFSKTDENNFKMFAVFCALALHCANMYHRIRHSECIYRVTMEKLSYHSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED 4DFF,6IJH,4AEL,2WEY,5SKV,5SKU,5SKT,5SKS,5SKR,5SKQ,5SKP,5SKO,5SKN,5SKM,5SKL,5SKK,5SKJ,5SKI,5SKH,5SKG,5SKF,5SKE,5SKD,5SKC,5SKB,5SKA,5SK9,5SK8,5SK7,5SK6,5SK5,5SK4,5SK3,5SK2,5SK1,5SK0,5SJZ,5SJY,5SJX,5SJW,5SJV,5SJU,5SJT,5SJS,5SJR,5SJQ,5SJP,5SJO,5SJN,5SJM,5SJL,5SJK,5SJJ,5SJI,5SJH,5SJG,5SJF,5SJE,5SJD,5SJC,5SJB,5SJA,5SJ9,5SJ8,5SJ7,5SJ6,5SJ5,5SJ4,5SJ3,5SJ2,5SJ1,5SJ0,5SIZ,5SIY,5SIX,5SIW,5SIV,5SIU,5SIT,5SIS,5SIR,5SIQ,5SIP,5SIO,5SIN,5SIM,5SIL,5SIK,5SIJ,5SII,5SIH,5SIG,5SIF,5SIE,5SID,5SIB,5SIA,5SI9,5SI8,5SI7,5SI6,5SI5,5SI4,5SI3,5SI2,5SI1,5SI0,5SHZ,5SHY,5SHX,5SHW,5SHV,5SHU,5SHT,5SHS,5SHR,5SHQ,5SHP,5SHO,5SHN,5SHM,5SHL cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A PDE10_HUMAN Q9Y233 A0A3F2YP58 Q6FHX1 Q9HCP9 Q9NTV4 Q9ULW9 Q9Y5T1 1451624 Cn1cc(c(n1)-c1ccc(OCc2cc(C(O)=O)c3ccccc3n2)cc1)-c1ccncc1 InChI=1S/C26H20N4O3/c1-30-15-23(17-10-12-27-13-11-17)25(29-30)18-6-8-20(9-7-18)33-16-19-14-22(26(31)32)21-4-2-3-5-24(21)28-19/h2-15H,16H2,1H3,(H,31,32) YACPWBQJXFYNKW-UHFFFAOYSA-N 700216 Ammonium 2-[[4-[1-methyl-4-(4-pyridyl)pyrazol-3-yl]phenoxy]methyl]quinoline-4-carboxylate::US20240336591, Example 4 cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A isoform 2 Homo sapiens 0.079 US Patent 10.7270/Q29G5S87 aid2060456 US20240336591 PATIENT, L; ALMOND-THYNNE, J; UNSWORTH, PJ; YIP, AC; ROBAS, N; BELICH, MP 10/10/2024 2/10/2025 Benevolentai Cambridge http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=700216 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8174&target=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A+isoform+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=700216&enzyme=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A+isoform+2&column=ki&startPg=0&Increment=50&submit=Search 167444537 505949286 1 MEDGPSNNASCFRRLTECFLSPSLTDEKVKAYLSLHPQVLDEFVSESVSAETVEKWLKRKNNKSEDESAPKEVSRYQDTNMQGVVYELNSYIEQRLDTGGDNQLLLYELSSIIKIATKADGFALYFLGECNNSLCIFTPPGIKEGKPRLIPAGPITQGTTVSAYVAKSRKTLLVEDILGDERFPRGTGLESGTRIQSVLCLPIVTAIGDLIGILELYRHWGKEAFCLSHQEVATANLAWASVAIHQVQVCRGLAKQTELNDFLLDVSKTYFDNIVAIDSLLEHIMIYAKNLVNADRCALFQVDHKNKELYSDLFDIGEEKEGKPVFKKTKEIRFSIEKGIAGQVARTGEVLNIPDAYADPRFNREVDLYTGYTTRNILCMPIVSRGSVIGVVQMVNKISGSAFSKTDENNFKMFAVFCALALHCANMYHRIRHSECIYRVTMEKLSYHSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED 4DFF,6IJH,4AEL,2WEY,5SKV,5SKU,5SKT,5SKS,5SKR,5SKQ,5SKP,5SKO,5SKN,5SKM,5SKL,5SKK,5SKJ,5SKI,5SKH,5SKG,5SKF,5SKE,5SKD,5SKC,5SKB,5SKA,5SK9,5SK8,5SK7,5SK6,5SK5,5SK4,5SK3,5SK2,5SK1,5SK0,5SJZ,5SJY,5SJX,5SJW,5SJV,5SJU,5SJT,5SJS,5SJR,5SJQ,5SJP,5SJO,5SJN,5SJM,5SJL,5SJK,5SJJ,5SJI,5SJH,5SJG,5SJF,5SJE,5SJD,5SJC,5SJB,5SJA,5SJ9,5SJ8,5SJ7,5SJ6,5SJ5,5SJ4,5SJ3,5SJ2,5SJ1,5SJ0,5SIZ,5SIY,5SIX,5SIW,5SIV,5SIU,5SIT,5SIS,5SIR,5SIQ,5SIP,5SIO,5SIN,5SIM,5SIL,5SIK,5SIJ,5SII,5SIH,5SIG,5SIF,5SIE,5SID,5SIB,5SIA,5SI9,5SI8,5SI7,5SI6,5SI5,5SI4,5SI3,5SI2,5SI1,5SI0,5SHZ,5SHY,5SHX,5SHW,5SHV,5SHU,5SHT,5SHS,5SHR,5SHQ,5SHP,5SHO,5SHN,5SHM,5SHL cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A PDE10_HUMAN Q9Y233 A0A3F2YP58 Q6FHX1 Q9HCP9 Q9NTV4 Q9ULW9 Q9Y5T1 1451625 OC(=O)Cn1cc(c(n1)-c1ccc(OCc2ccc3ccccc3n2)cc1)-c1ccncc1 InChI=1S/C26H20N4O3/c31-25(32)16-30-15-23(18-11-13-27-14-12-18)26(29-30)20-6-9-22(10-7-20)33-17-21-8-5-19-3-1-2-4-24(19)28-21/h1-15H,16-17H2,(H,31,32) FVPYWKCVXLAFGQ-UHFFFAOYSA-N 700217 2-[4-(4-Pyridyl)-3-[4-(2-quinolylmethoxy)phenyl]pyrazol-1-yl]acetic acid::US20240336591, Example 5 cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A isoform 2 Homo sapiens 0.389 US Patent 10.7270/Q29G5S87 aid2060456 US20240336591 PATIENT, L; ALMOND-THYNNE, J; UNSWORTH, PJ; YIP, AC; ROBAS, N; BELICH, MP 10/10/2024 2/10/2025 Benevolentai Cambridge http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=700217 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8174&target=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A+isoform+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=700217&enzyme=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A+isoform+2&column=ki&startPg=0&Increment=50&submit=Search 150231735 505949287 1 MEDGPSNNASCFRRLTECFLSPSLTDEKVKAYLSLHPQVLDEFVSESVSAETVEKWLKRKNNKSEDESAPKEVSRYQDTNMQGVVYELNSYIEQRLDTGGDNQLLLYELSSIIKIATKADGFALYFLGECNNSLCIFTPPGIKEGKPRLIPAGPITQGTTVSAYVAKSRKTLLVEDILGDERFPRGTGLESGTRIQSVLCLPIVTAIGDLIGILELYRHWGKEAFCLSHQEVATANLAWASVAIHQVQVCRGLAKQTELNDFLLDVSKTYFDNIVAIDSLLEHIMIYAKNLVNADRCALFQVDHKNKELYSDLFDIGEEKEGKPVFKKTKEIRFSIEKGIAGQVARTGEVLNIPDAYADPRFNREVDLYTGYTTRNILCMPIVSRGSVIGVVQMVNKISGSAFSKTDENNFKMFAVFCALALHCANMYHRIRHSECIYRVTMEKLSYHSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED 4DFF,6IJH,4AEL,2WEY,5SKV,5SKU,5SKT,5SKS,5SKR,5SKQ,5SKP,5SKO,5SKN,5SKM,5SKL,5SKK,5SKJ,5SKI,5SKH,5SKG,5SKF,5SKE,5SKD,5SKC,5SKB,5SKA,5SK9,5SK8,5SK7,5SK6,5SK5,5SK4,5SK3,5SK2,5SK1,5SK0,5SJZ,5SJY,5SJX,5SJW,5SJV,5SJU,5SJT,5SJS,5SJR,5SJQ,5SJP,5SJO,5SJN,5SJM,5SJL,5SJK,5SJJ,5SJI,5SJH,5SJG,5SJF,5SJE,5SJD,5SJC,5SJB,5SJA,5SJ9,5SJ8,5SJ7,5SJ6,5SJ5,5SJ4,5SJ3,5SJ2,5SJ1,5SJ0,5SIZ,5SIY,5SIX,5SIW,5SIV,5SIU,5SIT,5SIS,5SIR,5SIQ,5SIP,5SIO,5SIN,5SIM,5SIL,5SIK,5SIJ,5SII,5SIH,5SIG,5SIF,5SIE,5SID,5SIB,5SIA,5SI9,5SI8,5SI7,5SI6,5SI5,5SI4,5SI3,5SI2,5SI1,5SI0,5SHZ,5SHY,5SHX,5SHW,5SHV,5SHU,5SHT,5SHS,5SHR,5SHQ,5SHP,5SHO,5SHN,5SHM,5SHL cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A PDE10_HUMAN Q9Y233 A0A3F2YP58 Q6FHX1 Q9HCP9 Q9NTV4 Q9ULW9 Q9Y5T1 1451626 CS(=O)(=O)n1cc(c(n1)-c1ccc(OCc2ccc3ccccc3n2)cc1)-c1ccncc1 InChI=1S/C25H20N4O3S/c1-33(30,31)29-16-23(18-12-14-26-15-13-18)25(28-29)20-7-10-22(11-8-20)32-17-21-9-6-19-4-2-3-5-24(19)27-21/h2-16H,17H2,1H3 AOWBXKVQULQNFG-UHFFFAOYSA-N 700218 2-[[4-[1-Methylsulfonyl-4-(4-pyridyl)pyrazol-3-yl]phenoxy]methyl]quinoline::US20240336591, Example 6 cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A isoform 2 Homo sapiens 4.37 US Patent 10.7270/Q29G5S87 aid2060456 US20240336591 PATIENT, L; ALMOND-THYNNE, J; UNSWORTH, PJ; YIP, AC; ROBAS, N; BELICH, MP 10/10/2024 2/10/2025 Benevolentai Cambridge http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=700218 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8174&target=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A+isoform+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=700218&enzyme=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A+isoform+2&column=ki&startPg=0&Increment=50&submit=Search 167444617 505949288 1 MEDGPSNNASCFRRLTECFLSPSLTDEKVKAYLSLHPQVLDEFVSESVSAETVEKWLKRKNNKSEDESAPKEVSRYQDTNMQGVVYELNSYIEQRLDTGGDNQLLLYELSSIIKIATKADGFALYFLGECNNSLCIFTPPGIKEGKPRLIPAGPITQGTTVSAYVAKSRKTLLVEDILGDERFPRGTGLESGTRIQSVLCLPIVTAIGDLIGILELYRHWGKEAFCLSHQEVATANLAWASVAIHQVQVCRGLAKQTELNDFLLDVSKTYFDNIVAIDSLLEHIMIYAKNLVNADRCALFQVDHKNKELYSDLFDIGEEKEGKPVFKKTKEIRFSIEKGIAGQVARTGEVLNIPDAYADPRFNREVDLYTGYTTRNILCMPIVSRGSVIGVVQMVNKISGSAFSKTDENNFKMFAVFCALALHCANMYHRIRHSECIYRVTMEKLSYHSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED 4DFF,6IJH,4AEL,2WEY,5SKV,5SKU,5SKT,5SKS,5SKR,5SKQ,5SKP,5SKO,5SKN,5SKM,5SKL,5SKK,5SKJ,5SKI,5SKH,5SKG,5SKF,5SKE,5SKD,5SKC,5SKB,5SKA,5SK9,5SK8,5SK7,5SK6,5SK5,5SK4,5SK3,5SK2,5SK1,5SK0,5SJZ,5SJY,5SJX,5SJW,5SJV,5SJU,5SJT,5SJS,5SJR,5SJQ,5SJP,5SJO,5SJN,5SJM,5SJL,5SJK,5SJJ,5SJI,5SJH,5SJG,5SJF,5SJE,5SJD,5SJC,5SJB,5SJA,5SJ9,5SJ8,5SJ7,5SJ6,5SJ5,5SJ4,5SJ3,5SJ2,5SJ1,5SJ0,5SIZ,5SIY,5SIX,5SIW,5SIV,5SIU,5SIT,5SIS,5SIR,5SIQ,5SIP,5SIO,5SIN,5SIM,5SIL,5SIK,5SIJ,5SII,5SIH,5SIG,5SIF,5SIE,5SID,5SIB,5SIA,5SI9,5SI8,5SI7,5SI6,5SI5,5SI4,5SI3,5SI2,5SI1,5SI0,5SHZ,5SHY,5SHX,5SHW,5SHV,5SHU,5SHT,5SHS,5SHR,5SHQ,5SHP,5SHO,5SHN,5SHM,5SHL cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A PDE10_HUMAN Q9Y233 A0A3F2YP58 Q6FHX1 Q9HCP9 Q9NTV4 Q9ULW9 Q9Y5T1 1451627 Cc1cccc2nc(COc3ccc(cc3)-c3nn(C)cc3-c3ccncc3)c(cc12)C(=O)N=S(C)(C)=O InChI=1S/C29H27N5O3S/c1-19-6-5-7-26-23(19)16-24(29(35)33-38(3,4)36)27(31-26)18-37-22-10-8-21(9-11-22)28-25(17-34(2)32-28)20-12-14-30-15-13-20/h5-17H,18H2,1-4H3 OTGPXNFTBKOICG-UHFFFAOYSA-N 700233 N-[Dimethyl(oxo)-λ6-sulfanylidene]-5-methyl-2-[[4-[1-methyl-4-(4-pyridyl)pyrazol-3-yl]phenoxy]methyl]quinoline-3-carboxamide::US20240336591, Example 7 cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A isoform 2 Homo sapiens 0.224 US Patent 10.7270/Q29G5S87 aid2060456 US20240336591 PATIENT, L; ALMOND-THYNNE, J; UNSWORTH, PJ; YIP, AC; ROBAS, N; BELICH, MP 10/10/2024 2/10/2025 Benevolentai Cambridge http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=700233 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8174&target=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A+isoform+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=700233&enzyme=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A+isoform+2&column=ki&startPg=0&Increment=50&submit=Search 169591690 505949303 1 MEDGPSNNASCFRRLTECFLSPSLTDEKVKAYLSLHPQVLDEFVSESVSAETVEKWLKRKNNKSEDESAPKEVSRYQDTNMQGVVYELNSYIEQRLDTGGDNQLLLYELSSIIKIATKADGFALYFLGECNNSLCIFTPPGIKEGKPRLIPAGPITQGTTVSAYVAKSRKTLLVEDILGDERFPRGTGLESGTRIQSVLCLPIVTAIGDLIGILELYRHWGKEAFCLSHQEVATANLAWASVAIHQVQVCRGLAKQTELNDFLLDVSKTYFDNIVAIDSLLEHIMIYAKNLVNADRCALFQVDHKNKELYSDLFDIGEEKEGKPVFKKTKEIRFSIEKGIAGQVARTGEVLNIPDAYADPRFNREVDLYTGYTTRNILCMPIVSRGSVIGVVQMVNKISGSAFSKTDENNFKMFAVFCALALHCANMYHRIRHSECIYRVTMEKLSYHSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED 4DFF,6IJH,4AEL,2WEY,5SKV,5SKU,5SKT,5SKS,5SKR,5SKQ,5SKP,5SKO,5SKN,5SKM,5SKL,5SKK,5SKJ,5SKI,5SKH,5SKG,5SKF,5SKE,5SKD,5SKC,5SKB,5SKA,5SK9,5SK8,5SK7,5SK6,5SK5,5SK4,5SK3,5SK2,5SK1,5SK0,5SJZ,5SJY,5SJX,5SJW,5SJV,5SJU,5SJT,5SJS,5SJR,5SJQ,5SJP,5SJO,5SJN,5SJM,5SJL,5SJK,5SJJ,5SJI,5SJH,5SJG,5SJF,5SJE,5SJD,5SJC,5SJB,5SJA,5SJ9,5SJ8,5SJ7,5SJ6,5SJ5,5SJ4,5SJ3,5SJ2,5SJ1,5SJ0,5SIZ,5SIY,5SIX,5SIW,5SIV,5SIU,5SIT,5SIS,5SIR,5SIQ,5SIP,5SIO,5SIN,5SIM,5SIL,5SIK,5SIJ,5SII,5SIH,5SIG,5SIF,5SIE,5SID,5SIB,5SIA,5SI9,5SI8,5SI7,5SI6,5SI5,5SI4,5SI3,5SI2,5SI1,5SI0,5SHZ,5SHY,5SHX,5SHW,5SHV,5SHU,5SHT,5SHS,5SHR,5SHQ,5SHP,5SHO,5SHN,5SHM,5SHL cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A PDE10_HUMAN Q9Y233 A0A3F2YP58 Q6FHX1 Q9HCP9 Q9NTV4 Q9ULW9 Q9Y5T1 1451628 CS(C)(=O)=NC(=O)c1cc(COc2ccc(cc2)-c2nn(CC(F)(F)F)cc2-c2ccncc2)nc2ccccc12 InChI=1S/C29H24F3N5O3S/c1-41(2,39)36-28(38)24-15-21(34-26-6-4-3-5-23(24)26)17-40-22-9-7-20(8-10-22)27-25(19-11-13-33-14-12-19)16-37(35-27)18-29(30,31)32/h3-16H,17-18H2,1-2H3 XQXPZKUMBJSRMN-UHFFFAOYSA-N 700235 N-[Dimethyl(oxo)-λ6-sulfanylidene]-2-[[4-[4-(4-pyridyl)-1-(2,2,2-trifluoroethyl)pyrazol-3-yl]phenoxy]methyl]quinoline-4-carboxamide::US20240336591, Example 8 cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A isoform 2 Homo sapiens 0.063 US Patent 10.7270/Q29G5S87 aid2060456 US20240336591 PATIENT, L; ALMOND-THYNNE, J; UNSWORTH, PJ; YIP, AC; ROBAS, N; BELICH, MP 10/10/2024 2/10/2025 Benevolentai Cambridge http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=700235 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8174&target=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A+isoform+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=700235&enzyme=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A+isoform+2&column=ki&startPg=0&Increment=50&submit=Search 167444628 505949305 1 MEDGPSNNASCFRRLTECFLSPSLTDEKVKAYLSLHPQVLDEFVSESVSAETVEKWLKRKNNKSEDESAPKEVSRYQDTNMQGVVYELNSYIEQRLDTGGDNQLLLYELSSIIKIATKADGFALYFLGECNNSLCIFTPPGIKEGKPRLIPAGPITQGTTVSAYVAKSRKTLLVEDILGDERFPRGTGLESGTRIQSVLCLPIVTAIGDLIGILELYRHWGKEAFCLSHQEVATANLAWASVAIHQVQVCRGLAKQTELNDFLLDVSKTYFDNIVAIDSLLEHIMIYAKNLVNADRCALFQVDHKNKELYSDLFDIGEEKEGKPVFKKTKEIRFSIEKGIAGQVARTGEVLNIPDAYADPRFNREVDLYTGYTTRNILCMPIVSRGSVIGVVQMVNKISGSAFSKTDENNFKMFAVFCALALHCANMYHRIRHSECIYRVTMEKLSYHSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED 4DFF,6IJH,4AEL,2WEY,5SKV,5SKU,5SKT,5SKS,5SKR,5SKQ,5SKP,5SKO,5SKN,5SKM,5SKL,5SKK,5SKJ,5SKI,5SKH,5SKG,5SKF,5SKE,5SKD,5SKC,5SKB,5SKA,5SK9,5SK8,5SK7,5SK6,5SK5,5SK4,5SK3,5SK2,5SK1,5SK0,5SJZ,5SJY,5SJX,5SJW,5SJV,5SJU,5SJT,5SJS,5SJR,5SJQ,5SJP,5SJO,5SJN,5SJM,5SJL,5SJK,5SJJ,5SJI,5SJH,5SJG,5SJF,5SJE,5SJD,5SJC,5SJB,5SJA,5SJ9,5SJ8,5SJ7,5SJ6,5SJ5,5SJ4,5SJ3,5SJ2,5SJ1,5SJ0,5SIZ,5SIY,5SIX,5SIW,5SIV,5SIU,5SIT,5SIS,5SIR,5SIQ,5SIP,5SIO,5SIN,5SIM,5SIL,5SIK,5SIJ,5SII,5SIH,5SIG,5SIF,5SIE,5SID,5SIB,5SIA,5SI9,5SI8,5SI7,5SI6,5SI5,5SI4,5SI3,5SI2,5SI1,5SI0,5SHZ,5SHY,5SHX,5SHW,5SHV,5SHU,5SHT,5SHS,5SHR,5SHQ,5SHP,5SHO,5SHN,5SHM,5SHL cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A PDE10_HUMAN Q9Y233 A0A3F2YP58 Q6FHX1 Q9HCP9 Q9NTV4 Q9ULW9 Q9Y5T1 1451629 Cn1cc(c(n1)-c1ccc(OCc2nc3ccccc3cc2C(=O)NS(C)(=O)=O)cc1)-c1ccncc1 InChI=1S/C27H23N5O4S/c1-32-16-23(18-11-13-28-14-12-18)26(30-32)19-7-9-21(10-8-19)36-17-25-22(27(33)31-37(2,34)35)15-20-5-3-4-6-24(20)29-25/h3-16H,17H2,1-2H3,(H,31,33) FPULNSQUYWXCSL-UHFFFAOYSA-N 700244 2-[[4-[1-Methyl-4-(4-pyridyl)pyrazol-3-yl]phenoxy]methyl]-N-methylsulfonyl-quinoline-3-carboxamide::US20240336591, Example 9::US20240343729, Reference Example B cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A isoform 2 Homo sapiens 0.079 US Patent 10.7270/Q29G5S87 aid2060456 US20240336591 PATIENT, L; ALMOND-THYNNE, J; UNSWORTH, PJ; YIP, AC; ROBAS, N; BELICH, MP 10/10/2024 2/10/2025 Benevolentai Cambridge http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=700244 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8174&target=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A+isoform+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=700244&enzyme=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A+isoform+2&column=ki&startPg=0&Increment=50&submit=Search 167444499 505949314 1 MEDGPSNNASCFRRLTECFLSPSLTDEKVKAYLSLHPQVLDEFVSESVSAETVEKWLKRKNNKSEDESAPKEVSRYQDTNMQGVVYELNSYIEQRLDTGGDNQLLLYELSSIIKIATKADGFALYFLGECNNSLCIFTPPGIKEGKPRLIPAGPITQGTTVSAYVAKSRKTLLVEDILGDERFPRGTGLESGTRIQSVLCLPIVTAIGDLIGILELYRHWGKEAFCLSHQEVATANLAWASVAIHQVQVCRGLAKQTELNDFLLDVSKTYFDNIVAIDSLLEHIMIYAKNLVNADRCALFQVDHKNKELYSDLFDIGEEKEGKPVFKKTKEIRFSIEKGIAGQVARTGEVLNIPDAYADPRFNREVDLYTGYTTRNILCMPIVSRGSVIGVVQMVNKISGSAFSKTDENNFKMFAVFCALALHCANMYHRIRHSECIYRVTMEKLSYHSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED 4DFF,6IJH,4AEL,2WEY,5SKV,5SKU,5SKT,5SKS,5SKR,5SKQ,5SKP,5SKO,5SKN,5SKM,5SKL,5SKK,5SKJ,5SKI,5SKH,5SKG,5SKF,5SKE,5SKD,5SKC,5SKB,5SKA,5SK9,5SK8,5SK7,5SK6,5SK5,5SK4,5SK3,5SK2,5SK1,5SK0,5SJZ,5SJY,5SJX,5SJW,5SJV,5SJU,5SJT,5SJS,5SJR,5SJQ,5SJP,5SJO,5SJN,5SJM,5SJL,5SJK,5SJJ,5SJI,5SJH,5SJG,5SJF,5SJE,5SJD,5SJC,5SJB,5SJA,5SJ9,5SJ8,5SJ7,5SJ6,5SJ5,5SJ4,5SJ3,5SJ2,5SJ1,5SJ0,5SIZ,5SIY,5SIX,5SIW,5SIV,5SIU,5SIT,5SIS,5SIR,5SIQ,5SIP,5SIO,5SIN,5SIM,5SIL,5SIK,5SIJ,5SII,5SIH,5SIG,5SIF,5SIE,5SID,5SIB,5SIA,5SI9,5SI8,5SI7,5SI6,5SI5,5SI4,5SI3,5SI2,5SI1,5SI0,5SHZ,5SHY,5SHX,5SHW,5SHV,5SHU,5SHT,5SHS,5SHR,5SHQ,5SHP,5SHO,5SHN,5SHM,5SHL cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A PDE10_HUMAN Q9Y233 A0A3F2YP58 Q6FHX1 Q9HCP9 Q9NTV4 Q9ULW9 Q9Y5T1 1451630 Cn1cc(c(n1)-c1ccc(OCc2nc3ccccc3cc2C(=O)N=S(C)(C)=O)cc1)-c1ccncc1 InChI=1S/C28H25N5O3S/c1-33-17-24(19-12-14-29-15-13-19)27(31-33)20-8-10-22(11-9-20)36-18-26-23(28(34)32-37(2,3)35)16-21-6-4-5-7-25(21)30-26/h4-17H,18H2,1-3H3 SDXMNGTZQVTUFW-UHFFFAOYSA-N 700248 N-[Dimethyl(oxo)- lambda6-sulfanylidene]-2- [4-[1-methyl-4-(4- pyridyl)pyrazol-3- yl]phenoxy]methyl] quinoline-3- carboxamide::US20240336591, Example 10::US20240343729, Reference Example C cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A isoform 2 Homo sapiens 0.100 US Patent 10.7270/Q29G5S87 aid2060456 US20240336591 PATIENT, L; ALMOND-THYNNE, J; UNSWORTH, PJ; YIP, AC; ROBAS, N; BELICH, MP 10/10/2024 2/10/2025 Benevolentai Cambridge http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=700248 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8174&target=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A+isoform+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=700248&enzyme=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A+isoform+2&column=ki&startPg=0&Increment=50&submit=Search 167444674 505949318 1 MEDGPSNNASCFRRLTECFLSPSLTDEKVKAYLSLHPQVLDEFVSESVSAETVEKWLKRKNNKSEDESAPKEVSRYQDTNMQGVVYELNSYIEQRLDTGGDNQLLLYELSSIIKIATKADGFALYFLGECNNSLCIFTPPGIKEGKPRLIPAGPITQGTTVSAYVAKSRKTLLVEDILGDERFPRGTGLESGTRIQSVLCLPIVTAIGDLIGILELYRHWGKEAFCLSHQEVATANLAWASVAIHQVQVCRGLAKQTELNDFLLDVSKTYFDNIVAIDSLLEHIMIYAKNLVNADRCALFQVDHKNKELYSDLFDIGEEKEGKPVFKKTKEIRFSIEKGIAGQVARTGEVLNIPDAYADPRFNREVDLYTGYTTRNILCMPIVSRGSVIGVVQMVNKISGSAFSKTDENNFKMFAVFCALALHCANMYHRIRHSECIYRVTMEKLSYHSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED 4DFF,6IJH,4AEL,2WEY,5SKV,5SKU,5SKT,5SKS,5SKR,5SKQ,5SKP,5SKO,5SKN,5SKM,5SKL,5SKK,5SKJ,5SKI,5SKH,5SKG,5SKF,5SKE,5SKD,5SKC,5SKB,5SKA,5SK9,5SK8,5SK7,5SK6,5SK5,5SK4,5SK3,5SK2,5SK1,5SK0,5SJZ,5SJY,5SJX,5SJW,5SJV,5SJU,5SJT,5SJS,5SJR,5SJQ,5SJP,5SJO,5SJN,5SJM,5SJL,5SJK,5SJJ,5SJI,5SJH,5SJG,5SJF,5SJE,5SJD,5SJC,5SJB,5SJA,5SJ9,5SJ8,5SJ7,5SJ6,5SJ5,5SJ4,5SJ3,5SJ2,5SJ1,5SJ0,5SIZ,5SIY,5SIX,5SIW,5SIV,5SIU,5SIT,5SIS,5SIR,5SIQ,5SIP,5SIO,5SIN,5SIM,5SIL,5SIK,5SIJ,5SII,5SIH,5SIG,5SIF,5SIE,5SID,5SIB,5SIA,5SI9,5SI8,5SI7,5SI6,5SI5,5SI4,5SI3,5SI2,5SI1,5SI0,5SHZ,5SHY,5SHX,5SHW,5SHV,5SHU,5SHT,5SHS,5SHR,5SHQ,5SHP,5SHO,5SHN,5SHM,5SHL cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A PDE10_HUMAN Q9Y233 A0A3F2YP58 Q6FHX1 Q9HCP9 Q9NTV4 Q9ULW9 Q9Y5T1 1451631 Cn1cc(c(n1)-c1ccc(OCc2cc(C(=O)N=S(C)(C)=O)c3ccccc3n2)cc1)-c1ccncc1 InChI=1S/C28H25N5O3S/c1-33-17-25(19-12-14-29-15-13-19)27(31-33)20-8-10-22(11-9-20)36-18-21-16-24(28(34)32-37(2,3)35)23-6-4-5-7-26(23)30-21/h4-17H,18H2,1-3H3 ROVIGCIZIBAMFP-UHFFFAOYSA-N 700249 N-[Dimethyl(oxo)- lambda6-sulfanylidene]-2- [[4-[1-methyl-4-(4- pyridyl)pyrazol-3- yl]phenoxy]methyl] quinoline-4- carboxamide::US20240336591, Example 11::US20240343729, Reference Example D cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A isoform 2 Homo sapiens 0.079 US Patent 10.7270/Q29G5S87 aid2060456 US20240336591 PATIENT, L; ALMOND-THYNNE, J; UNSWORTH, PJ; YIP, AC; ROBAS, N; BELICH, MP 10/10/2024 2/10/2025 Benevolentai Cambridge http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=700249 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8174&target=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A+isoform+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=700249&enzyme=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A+isoform+2&column=ki&startPg=0&Increment=50&submit=Search 167444519 505949319 1 MEDGPSNNASCFRRLTECFLSPSLTDEKVKAYLSLHPQVLDEFVSESVSAETVEKWLKRKNNKSEDESAPKEVSRYQDTNMQGVVYELNSYIEQRLDTGGDNQLLLYELSSIIKIATKADGFALYFLGECNNSLCIFTPPGIKEGKPRLIPAGPITQGTTVSAYVAKSRKTLLVEDILGDERFPRGTGLESGTRIQSVLCLPIVTAIGDLIGILELYRHWGKEAFCLSHQEVATANLAWASVAIHQVQVCRGLAKQTELNDFLLDVSKTYFDNIVAIDSLLEHIMIYAKNLVNADRCALFQVDHKNKELYSDLFDIGEEKEGKPVFKKTKEIRFSIEKGIAGQVARTGEVLNIPDAYADPRFNREVDLYTGYTTRNILCMPIVSRGSVIGVVQMVNKISGSAFSKTDENNFKMFAVFCALALHCANMYHRIRHSECIYRVTMEKLSYHSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED 4DFF,6IJH,4AEL,2WEY,5SKV,5SKU,5SKT,5SKS,5SKR,5SKQ,5SKP,5SKO,5SKN,5SKM,5SKL,5SKK,5SKJ,5SKI,5SKH,5SKG,5SKF,5SKE,5SKD,5SKC,5SKB,5SKA,5SK9,5SK8,5SK7,5SK6,5SK5,5SK4,5SK3,5SK2,5SK1,5SK0,5SJZ,5SJY,5SJX,5SJW,5SJV,5SJU,5SJT,5SJS,5SJR,5SJQ,5SJP,5SJO,5SJN,5SJM,5SJL,5SJK,5SJJ,5SJI,5SJH,5SJG,5SJF,5SJE,5SJD,5SJC,5SJB,5SJA,5SJ9,5SJ8,5SJ7,5SJ6,5SJ5,5SJ4,5SJ3,5SJ2,5SJ1,5SJ0,5SIZ,5SIY,5SIX,5SIW,5SIV,5SIU,5SIT,5SIS,5SIR,5SIQ,5SIP,5SIO,5SIN,5SIM,5SIL,5SIK,5SIJ,5SII,5SIH,5SIG,5SIF,5SIE,5SID,5SIB,5SIA,5SI9,5SI8,5SI7,5SI6,5SI5,5SI4,5SI3,5SI2,5SI1,5SI0,5SHZ,5SHY,5SHX,5SHW,5SHV,5SHU,5SHT,5SHS,5SHR,5SHQ,5SHP,5SHO,5SHN,5SHM,5SHL cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A PDE10_HUMAN Q9Y233 A0A3F2YP58 Q6FHX1 Q9HCP9 Q9NTV4 Q9ULW9 Q9Y5T1 1451632 CS(C)(=O)=NC(=O)c1cc(COc2ccc(cc2)-c2n[nH]cc2-c2ccncc2)nc2ccccc12 InChI=1S/C27H23N5O3S/c1-36(2,34)32-27(33)23-15-20(30-25-6-4-3-5-22(23)25)17-35-21-9-7-19(8-10-21)26-24(16-29-31-26)18-11-13-28-14-12-18/h3-16H,17H2,1-2H3,(H,29,31) JMPPQMSJMFLPSN-UHFFFAOYSA-N 700250 N-[Dimethyl(oxo)- lambda6-sulfanylidene]-2- [[4-[4-(4-pyridyl)- 1H-pyrazol-3- yl]phenoxy]methyl] quinoline-4- carboxamide::US20240336591, Example 12 cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A isoform 2 Homo sapiens 0.145 US Patent 10.7270/Q29G5S87 aid2060456 US20240336591 PATIENT, L; ALMOND-THYNNE, J; UNSWORTH, PJ; YIP, AC; ROBAS, N; BELICH, MP 10/10/2024 2/10/2025 Benevolentai Cambridge http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=700250 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8174&target=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A+isoform+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=700250&enzyme=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A+isoform+2&column=ki&startPg=0&Increment=50&submit=Search 172675560 505949320 1 MEDGPSNNASCFRRLTECFLSPSLTDEKVKAYLSLHPQVLDEFVSESVSAETVEKWLKRKNNKSEDESAPKEVSRYQDTNMQGVVYELNSYIEQRLDTGGDNQLLLYELSSIIKIATKADGFALYFLGECNNSLCIFTPPGIKEGKPRLIPAGPITQGTTVSAYVAKSRKTLLVEDILGDERFPRGTGLESGTRIQSVLCLPIVTAIGDLIGILELYRHWGKEAFCLSHQEVATANLAWASVAIHQVQVCRGLAKQTELNDFLLDVSKTYFDNIVAIDSLLEHIMIYAKNLVNADRCALFQVDHKNKELYSDLFDIGEEKEGKPVFKKTKEIRFSIEKGIAGQVARTGEVLNIPDAYADPRFNREVDLYTGYTTRNILCMPIVSRGSVIGVVQMVNKISGSAFSKTDENNFKMFAVFCALALHCANMYHRIRHSECIYRVTMEKLSYHSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED 4DFF,6IJH,4AEL,2WEY,5SKV,5SKU,5SKT,5SKS,5SKR,5SKQ,5SKP,5SKO,5SKN,5SKM,5SKL,5SKK,5SKJ,5SKI,5SKH,5SKG,5SKF,5SKE,5SKD,5SKC,5SKB,5SKA,5SK9,5SK8,5SK7,5SK6,5SK5,5SK4,5SK3,5SK2,5SK1,5SK0,5SJZ,5SJY,5SJX,5SJW,5SJV,5SJU,5SJT,5SJS,5SJR,5SJQ,5SJP,5SJO,5SJN,5SJM,5SJL,5SJK,5SJJ,5SJI,5SJH,5SJG,5SJF,5SJE,5SJD,5SJC,5SJB,5SJA,5SJ9,5SJ8,5SJ7,5SJ6,5SJ5,5SJ4,5SJ3,5SJ2,5SJ1,5SJ0,5SIZ,5SIY,5SIX,5SIW,5SIV,5SIU,5SIT,5SIS,5SIR,5SIQ,5SIP,5SIO,5SIN,5SIM,5SIL,5SIK,5SIJ,5SII,5SIH,5SIG,5SIF,5SIE,5SID,5SIB,5SIA,5SI9,5SI8,5SI7,5SI6,5SI5,5SI4,5SI3,5SI2,5SI1,5SI0,5SHZ,5SHY,5SHX,5SHW,5SHV,5SHU,5SHT,5SHS,5SHR,5SHQ,5SHP,5SHO,5SHN,5SHM,5SHL cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A PDE10_HUMAN Q9Y233 A0A3F2YP58 Q6FHX1 Q9HCP9 Q9NTV4 Q9ULW9 Q9Y5T1 1451633 Cn1cc(c(n1)-c1ccc(OCc2nc3ccccc3cc2C(=O)N=S2(=O)CCCC2)cc1)-c1ccncc1 InChI=1S/C30H27N5O3S/c1-35-19-26(21-12-14-31-15-13-21)29(33-35)22-8-10-24(11-9-22)38-20-28-25(18-23-6-2-3-7-27(23)32-28)30(36)34-39(37)16-4-5-17-39/h2-3,6-15,18-19H,4-5,16-17,20H2,1H3 DVMVSSOOTOMSTF-UHFFFAOYSA-N 700251 2-[[4-[1-Methyl-4-(4- pyridyl)pyrazol-3- yl]phenoxy]methyl]- N-(1-oxothiolan-1- ylidene)quinoline-3- carboxamide::US20240336591, Example 13 cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A isoform 2 Homo sapiens 0.138 US Patent 10.7270/Q29G5S87 aid2060456 US20240336591 PATIENT, L; ALMOND-THYNNE, J; UNSWORTH, PJ; YIP, AC; ROBAS, N; BELICH, MP 10/10/2024 2/10/2025 Benevolentai Cambridge http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=700251 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8174&target=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A+isoform+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=700251&enzyme=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A+isoform+2&column=ki&startPg=0&Increment=50&submit=Search 167444568 505949321 1 MEDGPSNNASCFRRLTECFLSPSLTDEKVKAYLSLHPQVLDEFVSESVSAETVEKWLKRKNNKSEDESAPKEVSRYQDTNMQGVVYELNSYIEQRLDTGGDNQLLLYELSSIIKIATKADGFALYFLGECNNSLCIFTPPGIKEGKPRLIPAGPITQGTTVSAYVAKSRKTLLVEDILGDERFPRGTGLESGTRIQSVLCLPIVTAIGDLIGILELYRHWGKEAFCLSHQEVATANLAWASVAIHQVQVCRGLAKQTELNDFLLDVSKTYFDNIVAIDSLLEHIMIYAKNLVNADRCALFQVDHKNKELYSDLFDIGEEKEGKPVFKKTKEIRFSIEKGIAGQVARTGEVLNIPDAYADPRFNREVDLYTGYTTRNILCMPIVSRGSVIGVVQMVNKISGSAFSKTDENNFKMFAVFCALALHCANMYHRIRHSECIYRVTMEKLSYHSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED 4DFF,6IJH,4AEL,2WEY,5SKV,5SKU,5SKT,5SKS,5SKR,5SKQ,5SKP,5SKO,5SKN,5SKM,5SKL,5SKK,5SKJ,5SKI,5SKH,5SKG,5SKF,5SKE,5SKD,5SKC,5SKB,5SKA,5SK9,5SK8,5SK7,5SK6,5SK5,5SK4,5SK3,5SK2,5SK1,5SK0,5SJZ,5SJY,5SJX,5SJW,5SJV,5SJU,5SJT,5SJS,5SJR,5SJQ,5SJP,5SJO,5SJN,5SJM,5SJL,5SJK,5SJJ,5SJI,5SJH,5SJG,5SJF,5SJE,5SJD,5SJC,5SJB,5SJA,5SJ9,5SJ8,5SJ7,5SJ6,5SJ5,5SJ4,5SJ3,5SJ2,5SJ1,5SJ0,5SIZ,5SIY,5SIX,5SIW,5SIV,5SIU,5SIT,5SIS,5SIR,5SIQ,5SIP,5SIO,5SIN,5SIM,5SIL,5SIK,5SIJ,5SII,5SIH,5SIG,5SIF,5SIE,5SID,5SIB,5SIA,5SI9,5SI8,5SI7,5SI6,5SI5,5SI4,5SI3,5SI2,5SI1,5SI0,5SHZ,5SHY,5SHX,5SHW,5SHV,5SHU,5SHT,5SHS,5SHR,5SHQ,5SHP,5SHO,5SHN,5SHM,5SHL cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A PDE10_HUMAN Q9Y233 A0A3F2YP58 Q6FHX1 Q9HCP9 Q9NTV4 Q9ULW9 Q9Y5T1 1451634 Cn1cc(c(n1)-c1ccc(OCc2nc3ccccc3cc2C(=O)N=S(C)(=O)C2CC2)cc1)-c1ccncc1 InChI=1S/C30H27N5O3S/c1-35-18-26(20-13-15-31-16-14-20)29(33-35)21-7-9-23(10-8-21)38-19-28-25(17-22-5-3-4-6-27(22)32-28)30(36)34-39(2,37)24-11-12-24/h3-10,13-18,24H,11-12,19H2,1-2H3 YMCLVSBYNXWLJK-UHFFFAOYSA-N 700252 N-(Cyclopropyl- methyl-oxo-lambda6- sulfanylidene)-2-[[4- [1-methyl-4-(4- pyridyl)pyrazol-3- yl]phenoxy]methyl] quinoline-3- carboxamide::US20240336591, Example 14 cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A isoform 2 Homo sapiens 0.100 US Patent 10.7270/Q29G5S87 aid2060456 US20240336591 PATIENT, L; ALMOND-THYNNE, J; UNSWORTH, PJ; YIP, AC; ROBAS, N; BELICH, MP 10/10/2024 2/10/2025 Benevolentai Cambridge http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=700252 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8174&target=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A+isoform+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=700252&enzyme=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A+isoform+2&column=ki&startPg=0&Increment=50&submit=Search 169591611 505949322 1 MEDGPSNNASCFRRLTECFLSPSLTDEKVKAYLSLHPQVLDEFVSESVSAETVEKWLKRKNNKSEDESAPKEVSRYQDTNMQGVVYELNSYIEQRLDTGGDNQLLLYELSSIIKIATKADGFALYFLGECNNSLCIFTPPGIKEGKPRLIPAGPITQGTTVSAYVAKSRKTLLVEDILGDERFPRGTGLESGTRIQSVLCLPIVTAIGDLIGILELYRHWGKEAFCLSHQEVATANLAWASVAIHQVQVCRGLAKQTELNDFLLDVSKTYFDNIVAIDSLLEHIMIYAKNLVNADRCALFQVDHKNKELYSDLFDIGEEKEGKPVFKKTKEIRFSIEKGIAGQVARTGEVLNIPDAYADPRFNREVDLYTGYTTRNILCMPIVSRGSVIGVVQMVNKISGSAFSKTDENNFKMFAVFCALALHCANMYHRIRHSECIYRVTMEKLSYHSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED 4DFF,6IJH,4AEL,2WEY,5SKV,5SKU,5SKT,5SKS,5SKR,5SKQ,5SKP,5SKO,5SKN,5SKM,5SKL,5SKK,5SKJ,5SKI,5SKH,5SKG,5SKF,5SKE,5SKD,5SKC,5SKB,5SKA,5SK9,5SK8,5SK7,5SK6,5SK5,5SK4,5SK3,5SK2,5SK1,5SK0,5SJZ,5SJY,5SJX,5SJW,5SJV,5SJU,5SJT,5SJS,5SJR,5SJQ,5SJP,5SJO,5SJN,5SJM,5SJL,5SJK,5SJJ,5SJI,5SJH,5SJG,5SJF,5SJE,5SJD,5SJC,5SJB,5SJA,5SJ9,5SJ8,5SJ7,5SJ6,5SJ5,5SJ4,5SJ3,5SJ2,5SJ1,5SJ0,5SIZ,5SIY,5SIX,5SIW,5SIV,5SIU,5SIT,5SIS,5SIR,5SIQ,5SIP,5SIO,5SIN,5SIM,5SIL,5SIK,5SIJ,5SII,5SIH,5SIG,5SIF,5SIE,5SID,5SIB,5SIA,5SI9,5SI8,5SI7,5SI6,5SI5,5SI4,5SI3,5SI2,5SI1,5SI0,5SHZ,5SHY,5SHX,5SHW,5SHV,5SHU,5SHT,5SHS,5SHR,5SHQ,5SHP,5SHO,5SHN,5SHM,5SHL cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A PDE10_HUMAN Q9Y233 A0A3F2YP58 Q6FHX1 Q9HCP9 Q9NTV4 Q9ULW9 Q9Y5T1 1451635 CN(C(=O)c1cc2ccccc2nc1COc1ccc(cc1)-c1nn(C)cc1-c1ccncc1)S(C)(=O)=O InChI=1S/C28H25N5O4S/c1-32-17-24(19-12-14-29-15-13-19)27(31-32)20-8-10-22(11-9-20)37-18-26-23(28(34)33(2)38(3,35)36)16-21-6-4-5-7-25(21)30-26/h4-17H,18H2,1-3H3 KYHUFYGDHJWUAI-UHFFFAOYSA-N 700255 N-Methyl-2-[[4-[1-methyl-4-(4-pyridyl)pyrazol-3-yl]phenoxy]methyl]-N-methylsulfonyl-quinoline-3-carboxamide::US20240336591, Example 15 cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A isoform 2 Homo sapiens 0.603 US Patent 10.7270/Q29G5S87 aid2060456 US20240336591 PATIENT, L; ALMOND-THYNNE, J; UNSWORTH, PJ; YIP, AC; ROBAS, N; BELICH, MP 10/10/2024 2/10/2025 Benevolentai Cambridge http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=700255 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8174&target=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A+isoform+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=700255&enzyme=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A+isoform+2&column=ki&startPg=0&Increment=50&submit=Search 167444528 505949325 1 MEDGPSNNASCFRRLTECFLSPSLTDEKVKAYLSLHPQVLDEFVSESVSAETVEKWLKRKNNKSEDESAPKEVSRYQDTNMQGVVYELNSYIEQRLDTGGDNQLLLYELSSIIKIATKADGFALYFLGECNNSLCIFTPPGIKEGKPRLIPAGPITQGTTVSAYVAKSRKTLLVEDILGDERFPRGTGLESGTRIQSVLCLPIVTAIGDLIGILELYRHWGKEAFCLSHQEVATANLAWASVAIHQVQVCRGLAKQTELNDFLLDVSKTYFDNIVAIDSLLEHIMIYAKNLVNADRCALFQVDHKNKELYSDLFDIGEEKEGKPVFKKTKEIRFSIEKGIAGQVARTGEVLNIPDAYADPRFNREVDLYTGYTTRNILCMPIVSRGSVIGVVQMVNKISGSAFSKTDENNFKMFAVFCALALHCANMYHRIRHSECIYRVTMEKLSYHSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED 4DFF,6IJH,4AEL,2WEY,5SKV,5SKU,5SKT,5SKS,5SKR,5SKQ,5SKP,5SKO,5SKN,5SKM,5SKL,5SKK,5SKJ,5SKI,5SKH,5SKG,5SKF,5SKE,5SKD,5SKC,5SKB,5SKA,5SK9,5SK8,5SK7,5SK6,5SK5,5SK4,5SK3,5SK2,5SK1,5SK0,5SJZ,5SJY,5SJX,5SJW,5SJV,5SJU,5SJT,5SJS,5SJR,5SJQ,5SJP,5SJO,5SJN,5SJM,5SJL,5SJK,5SJJ,5SJI,5SJH,5SJG,5SJF,5SJE,5SJD,5SJC,5SJB,5SJA,5SJ9,5SJ8,5SJ7,5SJ6,5SJ5,5SJ4,5SJ3,5SJ2,5SJ1,5SJ0,5SIZ,5SIY,5SIX,5SIW,5SIV,5SIU,5SIT,5SIS,5SIR,5SIQ,5SIP,5SIO,5SIN,5SIM,5SIL,5SIK,5SIJ,5SII,5SIH,5SIG,5SIF,5SIE,5SID,5SIB,5SIA,5SI9,5SI8,5SI7,5SI6,5SI5,5SI4,5SI3,5SI2,5SI1,5SI0,5SHZ,5SHY,5SHX,5SHW,5SHV,5SHU,5SHT,5SHS,5SHR,5SHQ,5SHP,5SHO,5SHN,5SHM,5SHL cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A PDE10_HUMAN Q9Y233 A0A3F2YP58 Q6FHX1 Q9HCP9 Q9NTV4 Q9ULW9 Q9Y5T1 1451636 CN(C(=O)c1cc(COc2ccc(cc2)-c2nn(C)cc2-c2ccncc2)nc2ccccc12)S(C)(=O)=O InChI=1S/C28H25N5O4S/c1-32-17-25(19-12-14-29-15-13-19)27(31-32)20-8-10-22(11-9-20)37-18-21-16-24(28(34)33(2)38(3,35)36)23-6-4-5-7-26(23)30-21/h4-17H,18H2,1-3H3 PEQITAKNRJSRBH-UHFFFAOYSA-N 700256 N-Methyl-2-[[4-[1-methyl-4-(4-pyridyl)pyrazol-3-yl]phenoxy]methyl]-N-methylsulfonyl-quinoline-4-carboxamide::US20240336591, Example 16 cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A isoform 2 Homo sapiens 0.135 US Patent 10.7270/Q29G5S87 aid2060456 US20240336591 PATIENT, L; ALMOND-THYNNE, J; UNSWORTH, PJ; YIP, AC; ROBAS, N; BELICH, MP 10/10/2024 2/10/2025 Benevolentai Cambridge http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=700256 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8174&target=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A+isoform+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=700256&enzyme=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A+isoform+2&column=ki&startPg=0&Increment=50&submit=Search 167444514 505949326 1 MEDGPSNNASCFRRLTECFLSPSLTDEKVKAYLSLHPQVLDEFVSESVSAETVEKWLKRKNNKSEDESAPKEVSRYQDTNMQGVVYELNSYIEQRLDTGGDNQLLLYELSSIIKIATKADGFALYFLGECNNSLCIFTPPGIKEGKPRLIPAGPITQGTTVSAYVAKSRKTLLVEDILGDERFPRGTGLESGTRIQSVLCLPIVTAIGDLIGILELYRHWGKEAFCLSHQEVATANLAWASVAIHQVQVCRGLAKQTELNDFLLDVSKTYFDNIVAIDSLLEHIMIYAKNLVNADRCALFQVDHKNKELYSDLFDIGEEKEGKPVFKKTKEIRFSIEKGIAGQVARTGEVLNIPDAYADPRFNREVDLYTGYTTRNILCMPIVSRGSVIGVVQMVNKISGSAFSKTDENNFKMFAVFCALALHCANMYHRIRHSECIYRVTMEKLSYHSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED 4DFF,6IJH,4AEL,2WEY,5SKV,5SKU,5SKT,5SKS,5SKR,5SKQ,5SKP,5SKO,5SKN,5SKM,5SKL,5SKK,5SKJ,5SKI,5SKH,5SKG,5SKF,5SKE,5SKD,5SKC,5SKB,5SKA,5SK9,5SK8,5SK7,5SK6,5SK5,5SK4,5SK3,5SK2,5SK1,5SK0,5SJZ,5SJY,5SJX,5SJW,5SJV,5SJU,5SJT,5SJS,5SJR,5SJQ,5SJP,5SJO,5SJN,5SJM,5SJL,5SJK,5SJJ,5SJI,5SJH,5SJG,5SJF,5SJE,5SJD,5SJC,5SJB,5SJA,5SJ9,5SJ8,5SJ7,5SJ6,5SJ5,5SJ4,5SJ3,5SJ2,5SJ1,5SJ0,5SIZ,5SIY,5SIX,5SIW,5SIV,5SIU,5SIT,5SIS,5SIR,5SIQ,5SIP,5SIO,5SIN,5SIM,5SIL,5SIK,5SIJ,5SII,5SIH,5SIG,5SIF,5SIE,5SID,5SIB,5SIA,5SI9,5SI8,5SI7,5SI6,5SI5,5SI4,5SI3,5SI2,5SI1,5SI0,5SHZ,5SHY,5SHX,5SHW,5SHV,5SHU,5SHT,5SHS,5SHR,5SHQ,5SHP,5SHO,5SHN,5SHM,5SHL cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A PDE10_HUMAN Q9Y233 A0A3F2YP58 Q6FHX1 Q9HCP9 Q9NTV4 Q9ULW9 Q9Y5T1 1451637 Cn1cc(c(n1)-c1ccc(OCc2nc(C(=O)N=S(C)(C)=O)c3ccccc3n2)cc1)-c1ccncc1 InChI=1S/C27H24N6O3S/c1-33-16-22(18-12-14-28-15-13-18)25(31-33)19-8-10-20(11-9-19)36-17-24-29-23-7-5-4-6-21(23)26(30-24)27(34)32-37(2,3)35/h4-16H,17H2,1-3H3 NXFGYHQDWWWIDE-UHFFFAOYSA-N 700257 N-[Dimethyl(oxo)-λ6-sulfanylidene]-2-[[4-[1-methyl-4-(4-pyridyl)pyrazol-3-yl]phenoxy]methyl]quinazoline-4-carboxamide::US20240336591, Example 17::US20240343729, Reference Example E cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A isoform 2 Homo sapiens 0.120 US Patent 10.7270/Q29G5S87 aid2060456 US20240336591 PATIENT, L; ALMOND-THYNNE, J; UNSWORTH, PJ; YIP, AC; ROBAS, N; BELICH, MP 10/10/2024 2/10/2025 Benevolentai Cambridge http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=700257 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8174&target=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A+isoform+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=700257&enzyme=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A+isoform+2&column=ki&startPg=0&Increment=50&submit=Search 167444770 505949327 1 MEDGPSNNASCFRRLTECFLSPSLTDEKVKAYLSLHPQVLDEFVSESVSAETVEKWLKRKNNKSEDESAPKEVSRYQDTNMQGVVYELNSYIEQRLDTGGDNQLLLYELSSIIKIATKADGFALYFLGECNNSLCIFTPPGIKEGKPRLIPAGPITQGTTVSAYVAKSRKTLLVEDILGDERFPRGTGLESGTRIQSVLCLPIVTAIGDLIGILELYRHWGKEAFCLSHQEVATANLAWASVAIHQVQVCRGLAKQTELNDFLLDVSKTYFDNIVAIDSLLEHIMIYAKNLVNADRCALFQVDHKNKELYSDLFDIGEEKEGKPVFKKTKEIRFSIEKGIAGQVARTGEVLNIPDAYADPRFNREVDLYTGYTTRNILCMPIVSRGSVIGVVQMVNKISGSAFSKTDENNFKMFAVFCALALHCANMYHRIRHSECIYRVTMEKLSYHSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED 4DFF,6IJH,4AEL,2WEY,5SKV,5SKU,5SKT,5SKS,5SKR,5SKQ,5SKP,5SKO,5SKN,5SKM,5SKL,5SKK,5SKJ,5SKI,5SKH,5SKG,5SKF,5SKE,5SKD,5SKC,5SKB,5SKA,5SK9,5SK8,5SK7,5SK6,5SK5,5SK4,5SK3,5SK2,5SK1,5SK0,5SJZ,5SJY,5SJX,5SJW,5SJV,5SJU,5SJT,5SJS,5SJR,5SJQ,5SJP,5SJO,5SJN,5SJM,5SJL,5SJK,5SJJ,5SJI,5SJH,5SJG,5SJF,5SJE,5SJD,5SJC,5SJB,5SJA,5SJ9,5SJ8,5SJ7,5SJ6,5SJ5,5SJ4,5SJ3,5SJ2,5SJ1,5SJ0,5SIZ,5SIY,5SIX,5SIW,5SIV,5SIU,5SIT,5SIS,5SIR,5SIQ,5SIP,5SIO,5SIN,5SIM,5SIL,5SIK,5SIJ,5SII,5SIH,5SIG,5SIF,5SIE,5SID,5SIB,5SIA,5SI9,5SI8,5SI7,5SI6,5SI5,5SI4,5SI3,5SI2,5SI1,5SI0,5SHZ,5SHY,5SHX,5SHW,5SHV,5SHU,5SHT,5SHS,5SHR,5SHQ,5SHP,5SHO,5SHN,5SHM,5SHL cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A PDE10_HUMAN Q9Y233 A0A3F2YP58 Q6FHX1 Q9HCP9 Q9NTV4 Q9ULW9 Q9Y5T1 1451638 Cn1cc(c(n1)-c1ccc(OCc2nc3ccccc3nc2C(=O)N=S(C)(C)=O)cc1)-c1ccncc1 InChI=1S/C27H24N6O3S/c1-33-16-21(18-12-14-28-15-13-18)25(31-33)19-8-10-20(11-9-19)36-17-24-26(27(34)32-37(2,3)35)30-23-7-5-4-6-22(23)29-24/h4-16H,17H2,1-3H3 KJQVAJMZLMWADR-UHFFFAOYSA-N 700258 N-[Dimethyl(oxo)- lambda6-sulfanylidene]-3- [[4-[1-methyl-4-(4- pyridyl)pyrazol-3- yl]phenoxy]methyl] quinoxaline-2- carboxamide::US20240336591, Example 18 cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A isoform 2 Homo sapiens 0.457 US Patent 10.7270/Q29G5S87 aid2060456 US20240336591 PATIENT, L; ALMOND-THYNNE, J; UNSWORTH, PJ; YIP, AC; ROBAS, N; BELICH, MP 10/10/2024 2/10/2025 Benevolentai Cambridge http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=700258 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8174&target=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A+isoform+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=700258&enzyme=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A+isoform+2&column=ki&startPg=0&Increment=50&submit=Search 169591577 505949328 1 MEDGPSNNASCFRRLTECFLSPSLTDEKVKAYLSLHPQVLDEFVSESVSAETVEKWLKRKNNKSEDESAPKEVSRYQDTNMQGVVYELNSYIEQRLDTGGDNQLLLYELSSIIKIATKADGFALYFLGECNNSLCIFTPPGIKEGKPRLIPAGPITQGTTVSAYVAKSRKTLLVEDILGDERFPRGTGLESGTRIQSVLCLPIVTAIGDLIGILELYRHWGKEAFCLSHQEVATANLAWASVAIHQVQVCRGLAKQTELNDFLLDVSKTYFDNIVAIDSLLEHIMIYAKNLVNADRCALFQVDHKNKELYSDLFDIGEEKEGKPVFKKTKEIRFSIEKGIAGQVARTGEVLNIPDAYADPRFNREVDLYTGYTTRNILCMPIVSRGSVIGVVQMVNKISGSAFSKTDENNFKMFAVFCALALHCANMYHRIRHSECIYRVTMEKLSYHSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED 4DFF,6IJH,4AEL,2WEY,5SKV,5SKU,5SKT,5SKS,5SKR,5SKQ,5SKP,5SKO,5SKN,5SKM,5SKL,5SKK,5SKJ,5SKI,5SKH,5SKG,5SKF,5SKE,5SKD,5SKC,5SKB,5SKA,5SK9,5SK8,5SK7,5SK6,5SK5,5SK4,5SK3,5SK2,5SK1,5SK0,5SJZ,5SJY,5SJX,5SJW,5SJV,5SJU,5SJT,5SJS,5SJR,5SJQ,5SJP,5SJO,5SJN,5SJM,5SJL,5SJK,5SJJ,5SJI,5SJH,5SJG,5SJF,5SJE,5SJD,5SJC,5SJB,5SJA,5SJ9,5SJ8,5SJ7,5SJ6,5SJ5,5SJ4,5SJ3,5SJ2,5SJ1,5SJ0,5SIZ,5SIY,5SIX,5SIW,5SIV,5SIU,5SIT,5SIS,5SIR,5SIQ,5SIP,5SIO,5SIN,5SIM,5SIL,5SIK,5SIJ,5SII,5SIH,5SIG,5SIF,5SIE,5SID,5SIB,5SIA,5SI9,5SI8,5SI7,5SI6,5SI5,5SI4,5SI3,5SI2,5SI1,5SI0,5SHZ,5SHY,5SHX,5SHW,5SHV,5SHU,5SHT,5SHS,5SHR,5SHQ,5SHP,5SHO,5SHN,5SHM,5SHL cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A PDE10_HUMAN Q9Y233 A0A3F2YP58 Q6FHX1 Q9HCP9 Q9NTV4 Q9ULW9 Q9Y5T1 1451639 Cn1cc(c(n1)-c1ccc(OCc2nc3cccnc3cc2C(=O)N=S(C)(C)=O)cc1)-c1ccncc1 InChI=1S/C27H24N6O3S/c1-33-16-22(18-10-13-28-14-11-18)26(31-33)19-6-8-20(9-7-19)36-17-25-21(27(34)32-37(2,3)35)15-24-23(30-25)5-4-12-29-24/h4-16H,17H2,1-3H3 GGPBEJLBOLXENG-UHFFFAOYSA-N 700261 N-[Dimethyl(oxo)- lambda6-sulfanylidene]-2- [[4-[1-methyl-4-(4- pyridyl)pyrazol-3- yl]phenoxy]methyl]- 1,5-naphthyridine- 3-carboxamide::US20240336591, Example 19::US20240343729, Reference Example F cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A isoform 2 Homo sapiens 0.372 US Patent 10.7270/Q29G5S87 aid2060456 US20240336591 PATIENT, L; ALMOND-THYNNE, J; UNSWORTH, PJ; YIP, AC; ROBAS, N; BELICH, MP 10/10/2024 2/10/2025 Benevolentai Cambridge http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=700261 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8174&target=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A+isoform+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=700261&enzyme=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A+isoform+2&column=ki&startPg=0&Increment=50&submit=Search 169591455 505949331 1 MEDGPSNNASCFRRLTECFLSPSLTDEKVKAYLSLHPQVLDEFVSESVSAETVEKWLKRKNNKSEDESAPKEVSRYQDTNMQGVVYELNSYIEQRLDTGGDNQLLLYELSSIIKIATKADGFALYFLGECNNSLCIFTPPGIKEGKPRLIPAGPITQGTTVSAYVAKSRKTLLVEDILGDERFPRGTGLESGTRIQSVLCLPIVTAIGDLIGILELYRHWGKEAFCLSHQEVATANLAWASVAIHQVQVCRGLAKQTELNDFLLDVSKTYFDNIVAIDSLLEHIMIYAKNLVNADRCALFQVDHKNKELYSDLFDIGEEKEGKPVFKKTKEIRFSIEKGIAGQVARTGEVLNIPDAYADPRFNREVDLYTGYTTRNILCMPIVSRGSVIGVVQMVNKISGSAFSKTDENNFKMFAVFCALALHCANMYHRIRHSECIYRVTMEKLSYHSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED 4DFF,6IJH,4AEL,2WEY,5SKV,5SKU,5SKT,5SKS,5SKR,5SKQ,5SKP,5SKO,5SKN,5SKM,5SKL,5SKK,5SKJ,5SKI,5SKH,5SKG,5SKF,5SKE,5SKD,5SKC,5SKB,5SKA,5SK9,5SK8,5SK7,5SK6,5SK5,5SK4,5SK3,5SK2,5SK1,5SK0,5SJZ,5SJY,5SJX,5SJW,5SJV,5SJU,5SJT,5SJS,5SJR,5SJQ,5SJP,5SJO,5SJN,5SJM,5SJL,5SJK,5SJJ,5SJI,5SJH,5SJG,5SJF,5SJE,5SJD,5SJC,5SJB,5SJA,5SJ9,5SJ8,5SJ7,5SJ6,5SJ5,5SJ4,5SJ3,5SJ2,5SJ1,5SJ0,5SIZ,5SIY,5SIX,5SIW,5SIV,5SIU,5SIT,5SIS,5SIR,5SIQ,5SIP,5SIO,5SIN,5SIM,5SIL,5SIK,5SIJ,5SII,5SIH,5SIG,5SIF,5SIE,5SID,5SIB,5SIA,5SI9,5SI8,5SI7,5SI6,5SI5,5SI4,5SI3,5SI2,5SI1,5SI0,5SHZ,5SHY,5SHX,5SHW,5SHV,5SHU,5SHT,5SHS,5SHR,5SHQ,5SHP,5SHO,5SHN,5SHM,5SHL cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A PDE10_HUMAN Q9Y233 A0A3F2YP58 Q6FHX1 Q9HCP9 Q9NTV4 Q9ULW9 Q9Y5T1 1451640 Cn1cc(c(n1)-c1ccc(OCc2nc3ccccn3c2C(=O)N=S(C)(C)=O)cc1)-c1ccncc1 InChI=1S/C26H24N6O3S/c1-31-16-21(18-11-13-27-14-12-18)24(29-31)19-7-9-20(10-8-19)35-17-22-25(26(33)30-36(2,3)34)32-15-5-4-6-23(32)28-22/h4-16H,17H2,1-3H3 DBYHKDHOIPRXBN-UHFFFAOYSA-N 700263 N-[Dimethyl(oxo)- lambda6-sulfanylidene]-2- [[4-[1-methyl-4-(4- pyridyl)pyrazol-3- yl]phenoxy]methyl] imidazo[1,2- a]pyridine-3- carboxamide::US20240336591, Example 20::US20240343729, Reference Example G cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A isoform 2 Homo sapiens 0.174 US Patent 10.7270/Q29G5S87 aid2060456 US20240336591 PATIENT, L; ALMOND-THYNNE, J; UNSWORTH, PJ; YIP, AC; ROBAS, N; BELICH, MP 10/10/2024 2/10/2025 Benevolentai Cambridge http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=700263 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8174&target=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A+isoform+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=700263&enzyme=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A+isoform+2&column=ki&startPg=0&Increment=50&submit=Search 171569327 505949333 1 MEDGPSNNASCFRRLTECFLSPSLTDEKVKAYLSLHPQVLDEFVSESVSAETVEKWLKRKNNKSEDESAPKEVSRYQDTNMQGVVYELNSYIEQRLDTGGDNQLLLYELSSIIKIATKADGFALYFLGECNNSLCIFTPPGIKEGKPRLIPAGPITQGTTVSAYVAKSRKTLLVEDILGDERFPRGTGLESGTRIQSVLCLPIVTAIGDLIGILELYRHWGKEAFCLSHQEVATANLAWASVAIHQVQVCRGLAKQTELNDFLLDVSKTYFDNIVAIDSLLEHIMIYAKNLVNADRCALFQVDHKNKELYSDLFDIGEEKEGKPVFKKTKEIRFSIEKGIAGQVARTGEVLNIPDAYADPRFNREVDLYTGYTTRNILCMPIVSRGSVIGVVQMVNKISGSAFSKTDENNFKMFAVFCALALHCANMYHRIRHSECIYRVTMEKLSYHSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED 4DFF,6IJH,4AEL,2WEY,5SKV,5SKU,5SKT,5SKS,5SKR,5SKQ,5SKP,5SKO,5SKN,5SKM,5SKL,5SKK,5SKJ,5SKI,5SKH,5SKG,5SKF,5SKE,5SKD,5SKC,5SKB,5SKA,5SK9,5SK8,5SK7,5SK6,5SK5,5SK4,5SK3,5SK2,5SK1,5SK0,5SJZ,5SJY,5SJX,5SJW,5SJV,5SJU,5SJT,5SJS,5SJR,5SJQ,5SJP,5SJO,5SJN,5SJM,5SJL,5SJK,5SJJ,5SJI,5SJH,5SJG,5SJF,5SJE,5SJD,5SJC,5SJB,5SJA,5SJ9,5SJ8,5SJ7,5SJ6,5SJ5,5SJ4,5SJ3,5SJ2,5SJ1,5SJ0,5SIZ,5SIY,5SIX,5SIW,5SIV,5SIU,5SIT,5SIS,5SIR,5SIQ,5SIP,5SIO,5SIN,5SIM,5SIL,5SIK,5SIJ,5SII,5SIH,5SIG,5SIF,5SIE,5SID,5SIB,5SIA,5SI9,5SI8,5SI7,5SI6,5SI5,5SI4,5SI3,5SI2,5SI1,5SI0,5SHZ,5SHY,5SHX,5SHW,5SHV,5SHU,5SHT,5SHS,5SHR,5SHQ,5SHP,5SHO,5SHN,5SHM,5SHL cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A PDE10_HUMAN Q9Y233 A0A3F2YP58 Q6FHX1 Q9HCP9 Q9NTV4 Q9ULW9 Q9Y5T1 1451641 Cn1cc(c(n1)-c1ccc(OCc2nc3cc(F)ccc3cc2C(=O)N=S(C)(C)=O)cc1)-c1ccncc1 InChI=1S/C28H24FN5O3S/c1-34-16-24(18-10-12-30-13-11-18)27(32-34)19-5-8-22(9-6-19)37-17-26-23(28(35)33-38(2,3)36)14-20-4-7-21(29)15-25(20)31-26/h4-16H,17H2,1-3H3 IKYFZDXXUGHOPQ-UHFFFAOYSA-N 700264 N-[Dimethyl(oxo)-λ6-sulfanylidene]-7-fluoro-2-[[4-[l-methyl-4-(4-pyridyl)pyrazol-3-yl]phenoxy]methyl]quinoline-3-carboxamide::US20240336591, Example 21 cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A isoform 2 Homo sapiens 4.79 US Patent 10.7270/Q29G5S87 aid2060456 US20240336591 PATIENT, L; ALMOND-THYNNE, J; UNSWORTH, PJ; YIP, AC; ROBAS, N; BELICH, MP 10/10/2024 2/10/2025 Benevolentai Cambridge http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=700264 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8174&target=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A+isoform+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=700264&enzyme=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A+isoform+2&column=ki&startPg=0&Increment=50&submit=Search 167444623 505949334 1 MEDGPSNNASCFRRLTECFLSPSLTDEKVKAYLSLHPQVLDEFVSESVSAETVEKWLKRKNNKSEDESAPKEVSRYQDTNMQGVVYELNSYIEQRLDTGGDNQLLLYELSSIIKIATKADGFALYFLGECNNSLCIFTPPGIKEGKPRLIPAGPITQGTTVSAYVAKSRKTLLVEDILGDERFPRGTGLESGTRIQSVLCLPIVTAIGDLIGILELYRHWGKEAFCLSHQEVATANLAWASVAIHQVQVCRGLAKQTELNDFLLDVSKTYFDNIVAIDSLLEHIMIYAKNLVNADRCALFQVDHKNKELYSDLFDIGEEKEGKPVFKKTKEIRFSIEKGIAGQVARTGEVLNIPDAYADPRFNREVDLYTGYTTRNILCMPIVSRGSVIGVVQMVNKISGSAFSKTDENNFKMFAVFCALALHCANMYHRIRHSECIYRVTMEKLSYHSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED 4DFF,6IJH,4AEL,2WEY,5SKV,5SKU,5SKT,5SKS,5SKR,5SKQ,5SKP,5SKO,5SKN,5SKM,5SKL,5SKK,5SKJ,5SKI,5SKH,5SKG,5SKF,5SKE,5SKD,5SKC,5SKB,5SKA,5SK9,5SK8,5SK7,5SK6,5SK5,5SK4,5SK3,5SK2,5SK1,5SK0,5SJZ,5SJY,5SJX,5SJW,5SJV,5SJU,5SJT,5SJS,5SJR,5SJQ,5SJP,5SJO,5SJN,5SJM,5SJL,5SJK,5SJJ,5SJI,5SJH,5SJG,5SJF,5SJE,5SJD,5SJC,5SJB,5SJA,5SJ9,5SJ8,5SJ7,5SJ6,5SJ5,5SJ4,5SJ3,5SJ2,5SJ1,5SJ0,5SIZ,5SIY,5SIX,5SIW,5SIV,5SIU,5SIT,5SIS,5SIR,5SIQ,5SIP,5SIO,5SIN,5SIM,5SIL,5SIK,5SIJ,5SII,5SIH,5SIG,5SIF,5SIE,5SID,5SIB,5SIA,5SI9,5SI8,5SI7,5SI6,5SI5,5SI4,5SI3,5SI2,5SI1,5SI0,5SHZ,5SHY,5SHX,5SHW,5SHV,5SHU,5SHT,5SHS,5SHR,5SHQ,5SHP,5SHO,5SHN,5SHM,5SHL cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A PDE10_HUMAN Q9Y233 A0A3F2YP58 Q6FHX1 Q9HCP9 Q9NTV4 Q9ULW9 Q9Y5T1 1451642 Cn1cc(c(n1)-c1ccc(OCc2nc3ccc(F)cc3cc2C(=O)N=S(C)(C)=O)cc1)-c1ccncc1 InChI=1S/C28H24FN5O3S/c1-34-16-24(18-10-12-30-13-11-18)27(32-34)19-4-7-22(8-5-19)37-17-26-23(28(35)33-38(2,3)36)15-20-14-21(29)6-9-25(20)31-26/h4-16H,17H2,1-3H3 YZIZPNQHNRBMPM-UHFFFAOYSA-N 700268 N-[Dimethyl(oxo)-lambda6- sulfanylidene]-6- fluoro-2-[[4-[1- methyl-4-(4- pyridyl)pyrazol-3- yl]phenoxy]methyl] quinoline-3- carboxamide::US20240336591, Example 22 cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A isoform 2 Homo sapiens 0.324 US Patent 10.7270/Q29G5S87 aid2060456 US20240336591 PATIENT, L; ALMOND-THYNNE, J; UNSWORTH, PJ; YIP, AC; ROBAS, N; BELICH, MP 10/10/2024 2/10/2025 Benevolentai Cambridge http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=700268 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8174&target=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A+isoform+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=700268&enzyme=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A+isoform+2&column=ki&startPg=0&Increment=50&submit=Search 171569320 505949338 1 MEDGPSNNASCFRRLTECFLSPSLTDEKVKAYLSLHPQVLDEFVSESVSAETVEKWLKRKNNKSEDESAPKEVSRYQDTNMQGVVYELNSYIEQRLDTGGDNQLLLYELSSIIKIATKADGFALYFLGECNNSLCIFTPPGIKEGKPRLIPAGPITQGTTVSAYVAKSRKTLLVEDILGDERFPRGTGLESGTRIQSVLCLPIVTAIGDLIGILELYRHWGKEAFCLSHQEVATANLAWASVAIHQVQVCRGLAKQTELNDFLLDVSKTYFDNIVAIDSLLEHIMIYAKNLVNADRCALFQVDHKNKELYSDLFDIGEEKEGKPVFKKTKEIRFSIEKGIAGQVARTGEVLNIPDAYADPRFNREVDLYTGYTTRNILCMPIVSRGSVIGVVQMVNKISGSAFSKTDENNFKMFAVFCALALHCANMYHRIRHSECIYRVTMEKLSYHSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED 4DFF,6IJH,4AEL,2WEY,5SKV,5SKU,5SKT,5SKS,5SKR,5SKQ,5SKP,5SKO,5SKN,5SKM,5SKL,5SKK,5SKJ,5SKI,5SKH,5SKG,5SKF,5SKE,5SKD,5SKC,5SKB,5SKA,5SK9,5SK8,5SK7,5SK6,5SK5,5SK4,5SK3,5SK2,5SK1,5SK0,5SJZ,5SJY,5SJX,5SJW,5SJV,5SJU,5SJT,5SJS,5SJR,5SJQ,5SJP,5SJO,5SJN,5SJM,5SJL,5SJK,5SJJ,5SJI,5SJH,5SJG,5SJF,5SJE,5SJD,5SJC,5SJB,5SJA,5SJ9,5SJ8,5SJ7,5SJ6,5SJ5,5SJ4,5SJ3,5SJ2,5SJ1,5SJ0,5SIZ,5SIY,5SIX,5SIW,5SIV,5SIU,5SIT,5SIS,5SIR,5SIQ,5SIP,5SIO,5SIN,5SIM,5SIL,5SIK,5SIJ,5SII,5SIH,5SIG,5SIF,5SIE,5SID,5SIB,5SIA,5SI9,5SI8,5SI7,5SI6,5SI5,5SI4,5SI3,5SI2,5SI1,5SI0,5SHZ,5SHY,5SHX,5SHW,5SHV,5SHU,5SHT,5SHS,5SHR,5SHQ,5SHP,5SHO,5SHN,5SHM,5SHL cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A PDE10_HUMAN Q9Y233 A0A3F2YP58 Q6FHX1 Q9HCP9 Q9NTV4 Q9ULW9 Q9Y5T1 1451643 Cn1cc(c(n1)-c1ccc(OCc2nc3cccc(F)c3cc2C(=O)N=S(C)(C)=O)cc1)-c1ccncc1 InChI=1S/C28H24FN5O3S/c1-34-16-23(18-11-13-30-14-12-18)27(32-34)19-7-9-20(10-8-19)37-17-26-22(28(35)33-38(2,3)36)15-21-24(29)5-4-6-25(21)31-26/h4-16H,17H2,1-3H3 VCNCZEJRLGKNPE-UHFFFAOYSA-N 700269 N-[Dimethyl(oxo)-lambda6- sulfanylidene]-5- fluoro-2-[[4-[1- methyl-4-(4- pyridyl)pyrazol-3- yl]phenoxy]methyl] quinoline-3- carboxamide::US20240336591, Example 23 cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A isoform 2 Homo sapiens 0.257 US Patent 10.7270/Q29G5S87 aid2060456 US20240336591 PATIENT, L; ALMOND-THYNNE, J; UNSWORTH, PJ; YIP, AC; ROBAS, N; BELICH, MP 10/10/2024 2/10/2025 Benevolentai Cambridge http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=700269 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8174&target=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A+isoform+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=700269&enzyme=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A+isoform+2&column=ki&startPg=0&Increment=50&submit=Search 169591605 505949339 1 MEDGPSNNASCFRRLTECFLSPSLTDEKVKAYLSLHPQVLDEFVSESVSAETVEKWLKRKNNKSEDESAPKEVSRYQDTNMQGVVYELNSYIEQRLDTGGDNQLLLYELSSIIKIATKADGFALYFLGECNNSLCIFTPPGIKEGKPRLIPAGPITQGTTVSAYVAKSRKTLLVEDILGDERFPRGTGLESGTRIQSVLCLPIVTAIGDLIGILELYRHWGKEAFCLSHQEVATANLAWASVAIHQVQVCRGLAKQTELNDFLLDVSKTYFDNIVAIDSLLEHIMIYAKNLVNADRCALFQVDHKNKELYSDLFDIGEEKEGKPVFKKTKEIRFSIEKGIAGQVARTGEVLNIPDAYADPRFNREVDLYTGYTTRNILCMPIVSRGSVIGVVQMVNKISGSAFSKTDENNFKMFAVFCALALHCANMYHRIRHSECIYRVTMEKLSYHSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED 4DFF,6IJH,4AEL,2WEY,5SKV,5SKU,5SKT,5SKS,5SKR,5SKQ,5SKP,5SKO,5SKN,5SKM,5SKL,5SKK,5SKJ,5SKI,5SKH,5SKG,5SKF,5SKE,5SKD,5SKC,5SKB,5SKA,5SK9,5SK8,5SK7,5SK6,5SK5,5SK4,5SK3,5SK2,5SK1,5SK0,5SJZ,5SJY,5SJX,5SJW,5SJV,5SJU,5SJT,5SJS,5SJR,5SJQ,5SJP,5SJO,5SJN,5SJM,5SJL,5SJK,5SJJ,5SJI,5SJH,5SJG,5SJF,5SJE,5SJD,5SJC,5SJB,5SJA,5SJ9,5SJ8,5SJ7,5SJ6,5SJ5,5SJ4,5SJ3,5SJ2,5SJ1,5SJ0,5SIZ,5SIY,5SIX,5SIW,5SIV,5SIU,5SIT,5SIS,5SIR,5SIQ,5SIP,5SIO,5SIN,5SIM,5SIL,5SIK,5SIJ,5SII,5SIH,5SIG,5SIF,5SIE,5SID,5SIB,5SIA,5SI9,5SI8,5SI7,5SI6,5SI5,5SI4,5SI3,5SI2,5SI1,5SI0,5SHZ,5SHY,5SHX,5SHW,5SHV,5SHU,5SHT,5SHS,5SHR,5SHQ,5SHP,5SHO,5SHN,5SHM,5SHL cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A PDE10_HUMAN Q9Y233 A0A3F2YP58 Q6FHX1 Q9HCP9 Q9NTV4 Q9ULW9 Q9Y5T1 1451644 Cc1ccc2nc(COc3ccc(cc3)-c3nn(C)cc3-c3ccncc3)c(cc2c1)C(=O)N=S(C)(C)=O InChI=1S/C29H27N5O3S/c1-19-5-10-26-22(15-19)16-24(29(35)33-38(3,4)36)27(31-26)18-37-23-8-6-21(7-9-23)28-25(17-34(2)32-28)20-11-13-30-14-12-20/h5-17H,18H2,1-4H3 SLPXJTQHJVIWAC-UHFFFAOYSA-N 700272 N-[Dimethyl(oxo)-lambda6- sulfanylidene]-6- methyl-2-[[4-[1- methyl-4-(4- pyridyl)pyrazol-3- yl]phenoxy]methyl] quinoline-3- carboxamide::US20240336591, Example 24 cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A isoform 2 Homo sapiens 5.13 US Patent 10.7270/Q29G5S87 aid2060456 US20240336591 PATIENT, L; ALMOND-THYNNE, J; UNSWORTH, PJ; YIP, AC; ROBAS, N; BELICH, MP 10/10/2024 2/10/2025 Benevolentai Cambridge http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=700272 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8174&target=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A+isoform+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=700272&enzyme=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A+isoform+2&column=ki&startPg=0&Increment=50&submit=Search 169591606 505949342 1 MEDGPSNNASCFRRLTECFLSPSLTDEKVKAYLSLHPQVLDEFVSESVSAETVEKWLKRKNNKSEDESAPKEVSRYQDTNMQGVVYELNSYIEQRLDTGGDNQLLLYELSSIIKIATKADGFALYFLGECNNSLCIFTPPGIKEGKPRLIPAGPITQGTTVSAYVAKSRKTLLVEDILGDERFPRGTGLESGTRIQSVLCLPIVTAIGDLIGILELYRHWGKEAFCLSHQEVATANLAWASVAIHQVQVCRGLAKQTELNDFLLDVSKTYFDNIVAIDSLLEHIMIYAKNLVNADRCALFQVDHKNKELYSDLFDIGEEKEGKPVFKKTKEIRFSIEKGIAGQVARTGEVLNIPDAYADPRFNREVDLYTGYTTRNILCMPIVSRGSVIGVVQMVNKISGSAFSKTDENNFKMFAVFCALALHCANMYHRIRHSECIYRVTMEKLSYHSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED 4DFF,6IJH,4AEL,2WEY,5SKV,5SKU,5SKT,5SKS,5SKR,5SKQ,5SKP,5SKO,5SKN,5SKM,5SKL,5SKK,5SKJ,5SKI,5SKH,5SKG,5SKF,5SKE,5SKD,5SKC,5SKB,5SKA,5SK9,5SK8,5SK7,5SK6,5SK5,5SK4,5SK3,5SK2,5SK1,5SK0,5SJZ,5SJY,5SJX,5SJW,5SJV,5SJU,5SJT,5SJS,5SJR,5SJQ,5SJP,5SJO,5SJN,5SJM,5SJL,5SJK,5SJJ,5SJI,5SJH,5SJG,5SJF,5SJE,5SJD,5SJC,5SJB,5SJA,5SJ9,5SJ8,5SJ7,5SJ6,5SJ5,5SJ4,5SJ3,5SJ2,5SJ1,5SJ0,5SIZ,5SIY,5SIX,5SIW,5SIV,5SIU,5SIT,5SIS,5SIR,5SIQ,5SIP,5SIO,5SIN,5SIM,5SIL,5SIK,5SIJ,5SII,5SIH,5SIG,5SIF,5SIE,5SID,5SIB,5SIA,5SI9,5SI8,5SI7,5SI6,5SI5,5SI4,5SI3,5SI2,5SI1,5SI0,5SHZ,5SHY,5SHX,5SHW,5SHV,5SHU,5SHT,5SHS,5SHR,5SHQ,5SHP,5SHO,5SHN,5SHM,5SHL cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A PDE10_HUMAN Q9Y233 A0A3F2YP58 Q6FHX1 Q9HCP9 Q9NTV4 Q9ULW9 Q9Y5T1 1451645 Cn1cc(c(n1)-c1ccc(OCc2cc(C(=O)N=S(C)(C)=O)c3cc(F)ccc3n2)cc1)-c1ccncc1 InChI=1S/C28H24FN5O3S/c1-34-16-25(18-10-12-30-13-11-18)27(32-34)19-4-7-22(8-5-19)37-17-21-15-24(28(35)33-38(2,3)36)23-14-20(29)6-9-26(23)31-21/h4-16H,17H2,1-3H3 FLUNTRRHIVQDJC-UHFFFAOYSA-N 700278 N-[Dimethyl(oxo)-lambda6- sulfanylidene]-6- fluoro-2-[[4-[1- methyl-4-(4- pyridyl)pyrazol-3- yl]phenoxy]methyl] quinoline-4- carboxamide::US20240336591, Example 25 cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A isoform 2 Homo sapiens 0.389 US Patent 10.7270/Q29G5S87 aid2060456 US20240336591 PATIENT, L; ALMOND-THYNNE, J; UNSWORTH, PJ; YIP, AC; ROBAS, N; BELICH, MP 10/10/2024 2/10/2025 Benevolentai Cambridge http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=700278 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8174&target=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A+isoform+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=700278&enzyme=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A+isoform+2&column=ki&startPg=0&Increment=50&submit=Search 171569323 505949348 1 MEDGPSNNASCFRRLTECFLSPSLTDEKVKAYLSLHPQVLDEFVSESVSAETVEKWLKRKNNKSEDESAPKEVSRYQDTNMQGVVYELNSYIEQRLDTGGDNQLLLYELSSIIKIATKADGFALYFLGECNNSLCIFTPPGIKEGKPRLIPAGPITQGTTVSAYVAKSRKTLLVEDILGDERFPRGTGLESGTRIQSVLCLPIVTAIGDLIGILELYRHWGKEAFCLSHQEVATANLAWASVAIHQVQVCRGLAKQTELNDFLLDVSKTYFDNIVAIDSLLEHIMIYAKNLVNADRCALFQVDHKNKELYSDLFDIGEEKEGKPVFKKTKEIRFSIEKGIAGQVARTGEVLNIPDAYADPRFNREVDLYTGYTTRNILCMPIVSRGSVIGVVQMVNKISGSAFSKTDENNFKMFAVFCALALHCANMYHRIRHSECIYRVTMEKLSYHSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED 4DFF,6IJH,4AEL,2WEY,5SKV,5SKU,5SKT,5SKS,5SKR,5SKQ,5SKP,5SKO,5SKN,5SKM,5SKL,5SKK,5SKJ,5SKI,5SKH,5SKG,5SKF,5SKE,5SKD,5SKC,5SKB,5SKA,5SK9,5SK8,5SK7,5SK6,5SK5,5SK4,5SK3,5SK2,5SK1,5SK0,5SJZ,5SJY,5SJX,5SJW,5SJV,5SJU,5SJT,5SJS,5SJR,5SJQ,5SJP,5SJO,5SJN,5SJM,5SJL,5SJK,5SJJ,5SJI,5SJH,5SJG,5SJF,5SJE,5SJD,5SJC,5SJB,5SJA,5SJ9,5SJ8,5SJ7,5SJ6,5SJ5,5SJ4,5SJ3,5SJ2,5SJ1,5SJ0,5SIZ,5SIY,5SIX,5SIW,5SIV,5SIU,5SIT,5SIS,5SIR,5SIQ,5SIP,5SIO,5SIN,5SIM,5SIL,5SIK,5SIJ,5SII,5SIH,5SIG,5SIF,5SIE,5SID,5SIB,5SIA,5SI9,5SI8,5SI7,5SI6,5SI5,5SI4,5SI3,5SI2,5SI1,5SI0,5SHZ,5SHY,5SHX,5SHW,5SHV,5SHU,5SHT,5SHS,5SHR,5SHQ,5SHP,5SHO,5SHN,5SHM,5SHL cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A PDE10_HUMAN Q9Y233 A0A3F2YP58 Q6FHX1 Q9HCP9 Q9NTV4 Q9ULW9 Q9Y5T1 1451646 Cn1cc(c(n1)-c1ccc(OCc2cc(C(=O)N=S(C)(C)=O)c3c(Cl)cccc3n2)cc1)-c1ccncc1 InChI=1S/C28H24ClN5O3S/c1-34-16-23(18-11-13-30-14-12-18)27(32-34)19-7-9-21(10-8-19)37-17-20-15-22(28(35)33-38(2,3)36)26-24(29)5-4-6-25(26)31-20/h4-16H,17H2,1-3H3 DXAPMARJQHGLDB-UHFFFAOYSA-N 700279 5-Chloro-N- [Dimethyl(oxo)-lambda6- sulfanylidene]-2-[[4- [1-methyl-4-(4- pyridyl)pyrazol-3- yl]phenoxy]methyl] quinoline-4- carboxamide::US20240336591, Example 26 cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A isoform 2 Homo sapiens 0.741 US Patent 10.7270/Q29G5S87 aid2060456 US20240336591 PATIENT, L; ALMOND-THYNNE, J; UNSWORTH, PJ; YIP, AC; ROBAS, N; BELICH, MP 10/10/2024 2/10/2025 Benevolentai Cambridge http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=700279 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8174&target=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A+isoform+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=700279&enzyme=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A+isoform+2&column=ki&startPg=0&Increment=50&submit=Search 169591459 505949349 1 MEDGPSNNASCFRRLTECFLSPSLTDEKVKAYLSLHPQVLDEFVSESVSAETVEKWLKRKNNKSEDESAPKEVSRYQDTNMQGVVYELNSYIEQRLDTGGDNQLLLYELSSIIKIATKADGFALYFLGECNNSLCIFTPPGIKEGKPRLIPAGPITQGTTVSAYVAKSRKTLLVEDILGDERFPRGTGLESGTRIQSVLCLPIVTAIGDLIGILELYRHWGKEAFCLSHQEVATANLAWASVAIHQVQVCRGLAKQTELNDFLLDVSKTYFDNIVAIDSLLEHIMIYAKNLVNADRCALFQVDHKNKELYSDLFDIGEEKEGKPVFKKTKEIRFSIEKGIAGQVARTGEVLNIPDAYADPRFNREVDLYTGYTTRNILCMPIVSRGSVIGVVQMVNKISGSAFSKTDENNFKMFAVFCALALHCANMYHRIRHSECIYRVTMEKLSYHSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED 4DFF,6IJH,4AEL,2WEY,5SKV,5SKU,5SKT,5SKS,5SKR,5SKQ,5SKP,5SKO,5SKN,5SKM,5SKL,5SKK,5SKJ,5SKI,5SKH,5SKG,5SKF,5SKE,5SKD,5SKC,5SKB,5SKA,5SK9,5SK8,5SK7,5SK6,5SK5,5SK4,5SK3,5SK2,5SK1,5SK0,5SJZ,5SJY,5SJX,5SJW,5SJV,5SJU,5SJT,5SJS,5SJR,5SJQ,5SJP,5SJO,5SJN,5SJM,5SJL,5SJK,5SJJ,5SJI,5SJH,5SJG,5SJF,5SJE,5SJD,5SJC,5SJB,5SJA,5SJ9,5SJ8,5SJ7,5SJ6,5SJ5,5SJ4,5SJ3,5SJ2,5SJ1,5SJ0,5SIZ,5SIY,5SIX,5SIW,5SIV,5SIU,5SIT,5SIS,5SIR,5SIQ,5SIP,5SIO,5SIN,5SIM,5SIL,5SIK,5SIJ,5SII,5SIH,5SIG,5SIF,5SIE,5SID,5SIB,5SIA,5SI9,5SI8,5SI7,5SI6,5SI5,5SI4,5SI3,5SI2,5SI1,5SI0,5SHZ,5SHY,5SHX,5SHW,5SHV,5SHU,5SHT,5SHS,5SHR,5SHQ,5SHP,5SHO,5SHN,5SHM,5SHL cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A PDE10_HUMAN Q9Y233 A0A3F2YP58 Q6FHX1 Q9HCP9 Q9NTV4 Q9ULW9 Q9Y5T1 1451647 CCn1cc(c(n1)-c1ccc(OCc2cc(C(=O)N=S(C)(C)=O)c3ccccc3n2)cc1)-c1ccncc1 InChI=1S/C29H27N5O3S/c1-4-34-18-26(20-13-15-30-16-14-20)28(32-34)21-9-11-23(12-10-21)37-19-22-17-25(29(35)33-38(2,3)36)24-7-5-6-8-27(24)31-22/h5-18H,4,19H2,1-3H3 GKXKXVXIFOFQIY-UHFFFAOYSA-N 700280 N-[Dimethyl(oxo)-lambda6- sulfanylidene]-2-[[4- [1-ethyl-4-(4- pyridyl)pyrazol-3- yl]phenoxy]methyl] quinoline-4- carboxamide::US20240336591, Example 27 cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A isoform 2 Homo sapiens 0.063 US Patent 10.7270/Q29G5S87 aid2060456 US20240336591 PATIENT, L; ALMOND-THYNNE, J; UNSWORTH, PJ; YIP, AC; ROBAS, N; BELICH, MP 10/10/2024 2/10/2025 Benevolentai Cambridge http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=700280 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8174&target=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A+isoform+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=700280&enzyme=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A+isoform+2&column=ki&startPg=0&Increment=50&submit=Search 169591458 505949350 1 MEDGPSNNASCFRRLTECFLSPSLTDEKVKAYLSLHPQVLDEFVSESVSAETVEKWLKRKNNKSEDESAPKEVSRYQDTNMQGVVYELNSYIEQRLDTGGDNQLLLYELSSIIKIATKADGFALYFLGECNNSLCIFTPPGIKEGKPRLIPAGPITQGTTVSAYVAKSRKTLLVEDILGDERFPRGTGLESGTRIQSVLCLPIVTAIGDLIGILELYRHWGKEAFCLSHQEVATANLAWASVAIHQVQVCRGLAKQTELNDFLLDVSKTYFDNIVAIDSLLEHIMIYAKNLVNADRCALFQVDHKNKELYSDLFDIGEEKEGKPVFKKTKEIRFSIEKGIAGQVARTGEVLNIPDAYADPRFNREVDLYTGYTTRNILCMPIVSRGSVIGVVQMVNKISGSAFSKTDENNFKMFAVFCALALHCANMYHRIRHSECIYRVTMEKLSYHSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED 4DFF,6IJH,4AEL,2WEY,5SKV,5SKU,5SKT,5SKS,5SKR,5SKQ,5SKP,5SKO,5SKN,5SKM,5SKL,5SKK,5SKJ,5SKI,5SKH,5SKG,5SKF,5SKE,5SKD,5SKC,5SKB,5SKA,5SK9,5SK8,5SK7,5SK6,5SK5,5SK4,5SK3,5SK2,5SK1,5SK0,5SJZ,5SJY,5SJX,5SJW,5SJV,5SJU,5SJT,5SJS,5SJR,5SJQ,5SJP,5SJO,5SJN,5SJM,5SJL,5SJK,5SJJ,5SJI,5SJH,5SJG,5SJF,5SJE,5SJD,5SJC,5SJB,5SJA,5SJ9,5SJ8,5SJ7,5SJ6,5SJ5,5SJ4,5SJ3,5SJ2,5SJ1,5SJ0,5SIZ,5SIY,5SIX,5SIW,5SIV,5SIU,5SIT,5SIS,5SIR,5SIQ,5SIP,5SIO,5SIN,5SIM,5SIL,5SIK,5SIJ,5SII,5SIH,5SIG,5SIF,5SIE,5SID,5SIB,5SIA,5SI9,5SI8,5SI7,5SI6,5SI5,5SI4,5SI3,5SI2,5SI1,5SI0,5SHZ,5SHY,5SHX,5SHW,5SHV,5SHU,5SHT,5SHS,5SHR,5SHQ,5SHP,5SHO,5SHN,5SHM,5SHL cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A PDE10_HUMAN Q9Y233 A0A3F2YP58 Q6FHX1 Q9HCP9 Q9NTV4 Q9ULW9 Q9Y5T1 1451648 CS(C)(=O)=NC(=O)c1cc(COc2ccc(cc2)-c2nn(cc2-c2ccncc2)C2CC2)nc2ccccc12 InChI=1S/C30H27N5O3S/c1-39(2,37)34-30(36)26-17-22(32-28-6-4-3-5-25(26)28)19-38-24-11-7-21(8-12-24)29-27(20-13-15-31-16-14-20)18-35(33-29)23-9-10-23/h3-8,11-18,23H,9-10,19H2,1-2H3 YVJMCAOQNVFCSR-UHFFFAOYSA-N 700281 2-[[4-[1-Cyclopropyl- 4-(4-pyridyl)pyrazol- 3- yl]phenoxy]methyl]- N-[dimethyl(oxo)-lambda6- sulfanylidene] quinoline-4- carboxamide::US20240336591, Example 28 cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A isoform 2 Homo sapiens 0.380 US Patent 10.7270/Q29G5S87 aid2060456 US20240336591 PATIENT, L; ALMOND-THYNNE, J; UNSWORTH, PJ; YIP, AC; ROBAS, N; BELICH, MP 10/10/2024 2/10/2025 Benevolentai Cambridge http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=700281 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8174&target=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A+isoform+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=700281&enzyme=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A+isoform+2&column=ki&startPg=0&Increment=50&submit=Search 169591460 505949351 1 MEDGPSNNASCFRRLTECFLSPSLTDEKVKAYLSLHPQVLDEFVSESVSAETVEKWLKRKNNKSEDESAPKEVSRYQDTNMQGVVYELNSYIEQRLDTGGDNQLLLYELSSIIKIATKADGFALYFLGECNNSLCIFTPPGIKEGKPRLIPAGPITQGTTVSAYVAKSRKTLLVEDILGDERFPRGTGLESGTRIQSVLCLPIVTAIGDLIGILELYRHWGKEAFCLSHQEVATANLAWASVAIHQVQVCRGLAKQTELNDFLLDVSKTYFDNIVAIDSLLEHIMIYAKNLVNADRCALFQVDHKNKELYSDLFDIGEEKEGKPVFKKTKEIRFSIEKGIAGQVARTGEVLNIPDAYADPRFNREVDLYTGYTTRNILCMPIVSRGSVIGVVQMVNKISGSAFSKTDENNFKMFAVFCALALHCANMYHRIRHSECIYRVTMEKLSYHSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED 4DFF,6IJH,4AEL,2WEY,5SKV,5SKU,5SKT,5SKS,5SKR,5SKQ,5SKP,5SKO,5SKN,5SKM,5SKL,5SKK,5SKJ,5SKI,5SKH,5SKG,5SKF,5SKE,5SKD,5SKC,5SKB,5SKA,5SK9,5SK8,5SK7,5SK6,5SK5,5SK4,5SK3,5SK2,5SK1,5SK0,5SJZ,5SJY,5SJX,5SJW,5SJV,5SJU,5SJT,5SJS,5SJR,5SJQ,5SJP,5SJO,5SJN,5SJM,5SJL,5SJK,5SJJ,5SJI,5SJH,5SJG,5SJF,5SJE,5SJD,5SJC,5SJB,5SJA,5SJ9,5SJ8,5SJ7,5SJ6,5SJ5,5SJ4,5SJ3,5SJ2,5SJ1,5SJ0,5SIZ,5SIY,5SIX,5SIW,5SIV,5SIU,5SIT,5SIS,5SIR,5SIQ,5SIP,5SIO,5SIN,5SIM,5SIL,5SIK,5SIJ,5SII,5SIH,5SIG,5SIF,5SIE,5SID,5SIB,5SIA,5SI9,5SI8,5SI7,5SI6,5SI5,5SI4,5SI3,5SI2,5SI1,5SI0,5SHZ,5SHY,5SHX,5SHW,5SHV,5SHU,5SHT,5SHS,5SHR,5SHQ,5SHP,5SHO,5SHN,5SHM,5SHL cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A PDE10_HUMAN Q9Y233 A0A3F2YP58 Q6FHX1 Q9HCP9 Q9NTV4 Q9ULW9 Q9Y5T1 1451649 OC(=O)c1cc2ccccc2nc1COc1ccc(cc1)-c1n[nH]cc1-c1ccncc1 InChI=1S/C25H18N4O3/c30-25(31)20-13-18-3-1-2-4-22(18)28-23(20)15-32-19-7-5-17(6-8-19)24-21(14-27-29-24)16-9-11-26-12-10-16/h1-14H,15H2,(H,27,29)(H,30,31) WRHJTIHVZZCZMK-UHFFFAOYSA-N 700282 2-[[4-[4-(4-Pyridyl)-1H-pyrazol-3-yl]phenoxy]methyl]quinoline-3-carboxylic acid::US20240336591, Example 29 cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A isoform 2 Homo sapiens 0.100 US Patent 10.7270/Q29G5S87 aid2060456 US20240336591 PATIENT, L; ALMOND-THYNNE, J; UNSWORTH, PJ; YIP, AC; ROBAS, N; BELICH, MP 10/10/2024 2/10/2025 Benevolentai Cambridge http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=700282 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8174&target=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A+isoform+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=700282&enzyme=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A+isoform+2&column=ki&startPg=0&Increment=50&submit=Search 172675561 505949352 1 MEDGPSNNASCFRRLTECFLSPSLTDEKVKAYLSLHPQVLDEFVSESVSAETVEKWLKRKNNKSEDESAPKEVSRYQDTNMQGVVYELNSYIEQRLDTGGDNQLLLYELSSIIKIATKADGFALYFLGECNNSLCIFTPPGIKEGKPRLIPAGPITQGTTVSAYVAKSRKTLLVEDILGDERFPRGTGLESGTRIQSVLCLPIVTAIGDLIGILELYRHWGKEAFCLSHQEVATANLAWASVAIHQVQVCRGLAKQTELNDFLLDVSKTYFDNIVAIDSLLEHIMIYAKNLVNADRCALFQVDHKNKELYSDLFDIGEEKEGKPVFKKTKEIRFSIEKGIAGQVARTGEVLNIPDAYADPRFNREVDLYTGYTTRNILCMPIVSRGSVIGVVQMVNKISGSAFSKTDENNFKMFAVFCALALHCANMYHRIRHSECIYRVTMEKLSYHSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED 4DFF,6IJH,4AEL,2WEY,5SKV,5SKU,5SKT,5SKS,5SKR,5SKQ,5SKP,5SKO,5SKN,5SKM,5SKL,5SKK,5SKJ,5SKI,5SKH,5SKG,5SKF,5SKE,5SKD,5SKC,5SKB,5SKA,5SK9,5SK8,5SK7,5SK6,5SK5,5SK4,5SK3,5SK2,5SK1,5SK0,5SJZ,5SJY,5SJX,5SJW,5SJV,5SJU,5SJT,5SJS,5SJR,5SJQ,5SJP,5SJO,5SJN,5SJM,5SJL,5SJK,5SJJ,5SJI,5SJH,5SJG,5SJF,5SJE,5SJD,5SJC,5SJB,5SJA,5SJ9,5SJ8,5SJ7,5SJ6,5SJ5,5SJ4,5SJ3,5SJ2,5SJ1,5SJ0,5SIZ,5SIY,5SIX,5SIW,5SIV,5SIU,5SIT,5SIS,5SIR,5SIQ,5SIP,5SIO,5SIN,5SIM,5SIL,5SIK,5SIJ,5SII,5SIH,5SIG,5SIF,5SIE,5SID,5SIB,5SIA,5SI9,5SI8,5SI7,5SI6,5SI5,5SI4,5SI3,5SI2,5SI1,5SI0,5SHZ,5SHY,5SHX,5SHW,5SHV,5SHU,5SHT,5SHS,5SHR,5SHQ,5SHP,5SHO,5SHN,5SHM,5SHL cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A PDE10_HUMAN Q9Y233 A0A3F2YP58 Q6FHX1 Q9HCP9 Q9NTV4 Q9ULW9 Q9Y5T1 1451650 OC(=O)c1cc(COc2ccc(cc2)-c2n[nH]cc2-c2ccncc2)nc2ccccc12 InChI=1S/C25H18N4O3/c30-25(31)21-13-18(28-23-4-2-1-3-20(21)23)15-32-19-7-5-17(6-8-19)24-22(14-27-29-24)16-9-11-26-12-10-16/h1-14H,15H2,(H,27,29)(H,30,31) IWZFUDNUGHZBTH-UHFFFAOYSA-N 700283 2-[[4-[4-(4-Pyridyl)-1H-pyrazol-3-yl]phenoxy]methyl]quinoline-4-carboxylic acid::US20240336591, Example 30 cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A isoform 2 Homo sapiens 0.063 US Patent 10.7270/Q29G5S87 aid2060456 US20240336591 PATIENT, L; ALMOND-THYNNE, J; UNSWORTH, PJ; YIP, AC; ROBAS, N; BELICH, MP 10/10/2024 2/10/2025 Benevolentai Cambridge http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=700283 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8174&target=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A+isoform+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=700283&enzyme=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A+isoform+2&column=ki&startPg=0&Increment=50&submit=Search 172675562 505949353 1 MEDGPSNNASCFRRLTECFLSPSLTDEKVKAYLSLHPQVLDEFVSESVSAETVEKWLKRKNNKSEDESAPKEVSRYQDTNMQGVVYELNSYIEQRLDTGGDNQLLLYELSSIIKIATKADGFALYFLGECNNSLCIFTPPGIKEGKPRLIPAGPITQGTTVSAYVAKSRKTLLVEDILGDERFPRGTGLESGTRIQSVLCLPIVTAIGDLIGILELYRHWGKEAFCLSHQEVATANLAWASVAIHQVQVCRGLAKQTELNDFLLDVSKTYFDNIVAIDSLLEHIMIYAKNLVNADRCALFQVDHKNKELYSDLFDIGEEKEGKPVFKKTKEIRFSIEKGIAGQVARTGEVLNIPDAYADPRFNREVDLYTGYTTRNILCMPIVSRGSVIGVVQMVNKISGSAFSKTDENNFKMFAVFCALALHCANMYHRIRHSECIYRVTMEKLSYHSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED 4DFF,6IJH,4AEL,2WEY,5SKV,5SKU,5SKT,5SKS,5SKR,5SKQ,5SKP,5SKO,5SKN,5SKM,5SKL,5SKK,5SKJ,5SKI,5SKH,5SKG,5SKF,5SKE,5SKD,5SKC,5SKB,5SKA,5SK9,5SK8,5SK7,5SK6,5SK5,5SK4,5SK3,5SK2,5SK1,5SK0,5SJZ,5SJY,5SJX,5SJW,5SJV,5SJU,5SJT,5SJS,5SJR,5SJQ,5SJP,5SJO,5SJN,5SJM,5SJL,5SJK,5SJJ,5SJI,5SJH,5SJG,5SJF,5SJE,5SJD,5SJC,5SJB,5SJA,5SJ9,5SJ8,5SJ7,5SJ6,5SJ5,5SJ4,5SJ3,5SJ2,5SJ1,5SJ0,5SIZ,5SIY,5SIX,5SIW,5SIV,5SIU,5SIT,5SIS,5SIR,5SIQ,5SIP,5SIO,5SIN,5SIM,5SIL,5SIK,5SIJ,5SII,5SIH,5SIG,5SIF,5SIE,5SID,5SIB,5SIA,5SI9,5SI8,5SI7,5SI6,5SI5,5SI4,5SI3,5SI2,5SI1,5SI0,5SHZ,5SHY,5SHX,5SHW,5SHV,5SHU,5SHT,5SHS,5SHR,5SHQ,5SHP,5SHO,5SHN,5SHM,5SHL cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A PDE10_HUMAN Q9Y233 A0A3F2YP58 Q6FHX1 Q9HCP9 Q9NTV4 Q9ULW9 Q9Y5T1 1451651 CS(C)(=O)=NC(=O)c1cc2ccccc2nc1COc1ccc(cc1)-c1n[nH]cc1-c1ccncc1 InChI=1S/C27H23N5O3S/c1-36(2,34)32-27(33)22-15-20-5-3-4-6-24(20)30-25(22)17-35-21-9-7-19(8-10-21)26-23(16-29-31-26)18-11-13-28-14-12-18/h3-16H,17H2,1-2H3,(H,29,31) ZIYZMXRXYGCGJF-UHFFFAOYSA-N 700284 N-[Dimethyl(oxo)-λ6-sulfanylidene]-2-[[4-[4-(4-pyridyl)-1H-pyrazol-3-yl]phenoxy]methyl]quinoline-3-carboxamide::US20240336591, Example 31 cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A isoform 2 Homo sapiens 0.100 US Patent 10.7270/Q29G5S87 aid2060456 US20240336591 PATIENT, L; ALMOND-THYNNE, J; UNSWORTH, PJ; YIP, AC; ROBAS, N; BELICH, MP 10/10/2024 2/10/2025 Benevolentai Cambridge http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=700284 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8174&target=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A+isoform+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=700284&enzyme=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A+isoform+2&column=ki&startPg=0&Increment=50&submit=Search 172675563 505949354 1 MEDGPSNNASCFRRLTECFLSPSLTDEKVKAYLSLHPQVLDEFVSESVSAETVEKWLKRKNNKSEDESAPKEVSRYQDTNMQGVVYELNSYIEQRLDTGGDNQLLLYELSSIIKIATKADGFALYFLGECNNSLCIFTPPGIKEGKPRLIPAGPITQGTTVSAYVAKSRKTLLVEDILGDERFPRGTGLESGTRIQSVLCLPIVTAIGDLIGILELYRHWGKEAFCLSHQEVATANLAWASVAIHQVQVCRGLAKQTELNDFLLDVSKTYFDNIVAIDSLLEHIMIYAKNLVNADRCALFQVDHKNKELYSDLFDIGEEKEGKPVFKKTKEIRFSIEKGIAGQVARTGEVLNIPDAYADPRFNREVDLYTGYTTRNILCMPIVSRGSVIGVVQMVNKISGSAFSKTDENNFKMFAVFCALALHCANMYHRIRHSECIYRVTMEKLSYHSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED 4DFF,6IJH,4AEL,2WEY,5SKV,5SKU,5SKT,5SKS,5SKR,5SKQ,5SKP,5SKO,5SKN,5SKM,5SKL,5SKK,5SKJ,5SKI,5SKH,5SKG,5SKF,5SKE,5SKD,5SKC,5SKB,5SKA,5SK9,5SK8,5SK7,5SK6,5SK5,5SK4,5SK3,5SK2,5SK1,5SK0,5SJZ,5SJY,5SJX,5SJW,5SJV,5SJU,5SJT,5SJS,5SJR,5SJQ,5SJP,5SJO,5SJN,5SJM,5SJL,5SJK,5SJJ,5SJI,5SJH,5SJG,5SJF,5SJE,5SJD,5SJC,5SJB,5SJA,5SJ9,5SJ8,5SJ7,5SJ6,5SJ5,5SJ4,5SJ3,5SJ2,5SJ1,5SJ0,5SIZ,5SIY,5SIX,5SIW,5SIV,5SIU,5SIT,5SIS,5SIR,5SIQ,5SIP,5SIO,5SIN,5SIM,5SIL,5SIK,5SIJ,5SII,5SIH,5SIG,5SIF,5SIE,5SID,5SIB,5SIA,5SI9,5SI8,5SI7,5SI6,5SI5,5SI4,5SI3,5SI2,5SI1,5SI0,5SHZ,5SHY,5SHX,5SHW,5SHV,5SHU,5SHT,5SHS,5SHR,5SHQ,5SHP,5SHO,5SHN,5SHM,5SHL cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A PDE10_HUMAN Q9Y233 A0A3F2YP58 Q6FHX1 Q9HCP9 Q9NTV4 Q9ULW9 Q9Y5T1 1451652 CS(C)(=O)=Nc1cc(COc2ccc(cc2)-c2n[nH]cc2-c2ccncc2)nc2ccccc12 InChI=1S/C26H23N5O2S/c1-34(2,32)31-25-15-20(29-24-6-4-3-5-22(24)25)17-33-21-9-7-19(8-10-21)26-23(16-28-30-26)18-11-13-27-14-12-18/h3-16H,17H2,1-2H3,(H,28,30) RLESLYIEQJJFHN-UHFFFAOYSA-N 700285 Dimethyl-oxo-[[2-[[4-[4-(4-pyridyl)-1H-pyrazol-3-yl]phenoxy]methyl]-4-quinolyl]imino]-λ6-sulfane::US20240336591, Example 32 cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A isoform 2 Homo sapiens 0.050 US Patent 10.7270/Q29G5S87 aid2060456 US20240336591 PATIENT, L; ALMOND-THYNNE, J; UNSWORTH, PJ; YIP, AC; ROBAS, N; BELICH, MP 10/10/2024 2/10/2025 Benevolentai Cambridge http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=700285 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8174&target=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A+isoform+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=700285&enzyme=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A+isoform+2&column=ki&startPg=0&Increment=50&submit=Search 172675564 505949355 1 MEDGPSNNASCFRRLTECFLSPSLTDEKVKAYLSLHPQVLDEFVSESVSAETVEKWLKRKNNKSEDESAPKEVSRYQDTNMQGVVYELNSYIEQRLDTGGDNQLLLYELSSIIKIATKADGFALYFLGECNNSLCIFTPPGIKEGKPRLIPAGPITQGTTVSAYVAKSRKTLLVEDILGDERFPRGTGLESGTRIQSVLCLPIVTAIGDLIGILELYRHWGKEAFCLSHQEVATANLAWASVAIHQVQVCRGLAKQTELNDFLLDVSKTYFDNIVAIDSLLEHIMIYAKNLVNADRCALFQVDHKNKELYSDLFDIGEEKEGKPVFKKTKEIRFSIEKGIAGQVARTGEVLNIPDAYADPRFNREVDLYTGYTTRNILCMPIVSRGSVIGVVQMVNKISGSAFSKTDENNFKMFAVFCALALHCANMYHRIRHSECIYRVTMEKLSYHSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED 4DFF,6IJH,4AEL,2WEY,5SKV,5SKU,5SKT,5SKS,5SKR,5SKQ,5SKP,5SKO,5SKN,5SKM,5SKL,5SKK,5SKJ,5SKI,5SKH,5SKG,5SKF,5SKE,5SKD,5SKC,5SKB,5SKA,5SK9,5SK8,5SK7,5SK6,5SK5,5SK4,5SK3,5SK2,5SK1,5SK0,5SJZ,5SJY,5SJX,5SJW,5SJV,5SJU,5SJT,5SJS,5SJR,5SJQ,5SJP,5SJO,5SJN,5SJM,5SJL,5SJK,5SJJ,5SJI,5SJH,5SJG,5SJF,5SJE,5SJD,5SJC,5SJB,5SJA,5SJ9,5SJ8,5SJ7,5SJ6,5SJ5,5SJ4,5SJ3,5SJ2,5SJ1,5SJ0,5SIZ,5SIY,5SIX,5SIW,5SIV,5SIU,5SIT,5SIS,5SIR,5SIQ,5SIP,5SIO,5SIN,5SIM,5SIL,5SIK,5SIJ,5SII,5SIH,5SIG,5SIF,5SIE,5SID,5SIB,5SIA,5SI9,5SI8,5SI7,5SI6,5SI5,5SI4,5SI3,5SI2,5SI1,5SI0,5SHZ,5SHY,5SHX,5SHW,5SHV,5SHU,5SHT,5SHS,5SHR,5SHQ,5SHP,5SHO,5SHN,5SHM,5SHL cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A PDE10_HUMAN Q9Y233 A0A3F2YP58 Q6FHX1 Q9HCP9 Q9NTV4 Q9ULW9 Q9Y5T1 1451653 CS(=N)(=O)c1cc(COc2ccc(cc2)-c2n[nH]cc2-c2ccncc2)nc2ccccc12 InChI=1S/C25H21N5O2S/c1-33(26,31)24-14-19(29-23-5-3-2-4-21(23)24)16-32-20-8-6-18(7-9-20)25-22(15-28-30-25)17-10-12-27-13-11-17/h2-15,26H,16H2,1H3,(H,28,30) DRVPFEJFAIAPAT-UHFFFAOYSA-N 700286 Imino-methyl-oxo-[2-[[4-[4-(4-pyridyl)-1H-pyrazol-3-yl]phenoxy]methyl]-4-quinolyl]-λ6-sulfane::US20240336591, Example 33 cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A isoform 2 Homo sapiens 0.479 US Patent 10.7270/Q29G5S87 aid2060456 US20240336591 PATIENT, L; ALMOND-THYNNE, J; UNSWORTH, PJ; YIP, AC; ROBAS, N; BELICH, MP 10/10/2024 2/10/2025 Benevolentai Cambridge http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=700286 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8174&target=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A+isoform+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=700286&enzyme=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A+isoform+2&column=ki&startPg=0&Increment=50&submit=Search 172675565 505949356 1 MEDGPSNNASCFRRLTECFLSPSLTDEKVKAYLSLHPQVLDEFVSESVSAETVEKWLKRKNNKSEDESAPKEVSRYQDTNMQGVVYELNSYIEQRLDTGGDNQLLLYELSSIIKIATKADGFALYFLGECNNSLCIFTPPGIKEGKPRLIPAGPITQGTTVSAYVAKSRKTLLVEDILGDERFPRGTGLESGTRIQSVLCLPIVTAIGDLIGILELYRHWGKEAFCLSHQEVATANLAWASVAIHQVQVCRGLAKQTELNDFLLDVSKTYFDNIVAIDSLLEHIMIYAKNLVNADRCALFQVDHKNKELYSDLFDIGEEKEGKPVFKKTKEIRFSIEKGIAGQVARTGEVLNIPDAYADPRFNREVDLYTGYTTRNILCMPIVSRGSVIGVVQMVNKISGSAFSKTDENNFKMFAVFCALALHCANMYHRIRHSECIYRVTMEKLSYHSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED 4DFF,6IJH,4AEL,2WEY,5SKV,5SKU,5SKT,5SKS,5SKR,5SKQ,5SKP,5SKO,5SKN,5SKM,5SKL,5SKK,5SKJ,5SKI,5SKH,5SKG,5SKF,5SKE,5SKD,5SKC,5SKB,5SKA,5SK9,5SK8,5SK7,5SK6,5SK5,5SK4,5SK3,5SK2,5SK1,5SK0,5SJZ,5SJY,5SJX,5SJW,5SJV,5SJU,5SJT,5SJS,5SJR,5SJQ,5SJP,5SJO,5SJN,5SJM,5SJL,5SJK,5SJJ,5SJI,5SJH,5SJG,5SJF,5SJE,5SJD,5SJC,5SJB,5SJA,5SJ9,5SJ8,5SJ7,5SJ6,5SJ5,5SJ4,5SJ3,5SJ2,5SJ1,5SJ0,5SIZ,5SIY,5SIX,5SIW,5SIV,5SIU,5SIT,5SIS,5SIR,5SIQ,5SIP,5SIO,5SIN,5SIM,5SIL,5SIK,5SIJ,5SII,5SIH,5SIG,5SIF,5SIE,5SID,5SIB,5SIA,5SI9,5SI8,5SI7,5SI6,5SI5,5SI4,5SI3,5SI2,5SI1,5SI0,5SHZ,5SHY,5SHX,5SHW,5SHV,5SHU,5SHT,5SHS,5SHR,5SHQ,5SHP,5SHO,5SHN,5SHM,5SHL cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A PDE10_HUMAN Q9Y233 A0A3F2YP58 Q6FHX1 Q9HCP9 Q9NTV4 Q9ULW9 Q9Y5T1 1451654 Cn1cc(c(n1)-c1ccc(OCc2cc(NS(C)(=O)=O)c3ccccc3n2)cc1)-c1ccncc1 InChI=1S/C26H23N5O3S/c1-31-16-23(18-11-13-27-14-12-18)26(29-31)19-7-9-21(10-8-19)34-17-20-15-25(30-35(2,32)33)22-5-3-4-6-24(22)28-20/h3-16H,17H2,1-2H3,(H,28,30) WWQDWKACCWHBFR-UHFFFAOYSA-N 700287 N-[2-[[4-[1-Methyl-4-(4-pyridyl)pyrazol-3-yl]phenoxy]methyl]-4-quinolyl]methanesulfonamide::US20240336591, Example 34 cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A isoform 2 Homo sapiens 0.288 US Patent 10.7270/Q29G5S87 aid2060456 US20240336591 PATIENT, L; ALMOND-THYNNE, J; UNSWORTH, PJ; YIP, AC; ROBAS, N; BELICH, MP 10/10/2024 2/10/2025 Benevolentai Cambridge http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=700287 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8174&target=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A+isoform+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=700287&enzyme=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A+isoform+2&column=ki&startPg=0&Increment=50&submit=Search 167444521 505949357 1 MEDGPSNNASCFRRLTECFLSPSLTDEKVKAYLSLHPQVLDEFVSESVSAETVEKWLKRKNNKSEDESAPKEVSRYQDTNMQGVVYELNSYIEQRLDTGGDNQLLLYELSSIIKIATKADGFALYFLGECNNSLCIFTPPGIKEGKPRLIPAGPITQGTTVSAYVAKSRKTLLVEDILGDERFPRGTGLESGTRIQSVLCLPIVTAIGDLIGILELYRHWGKEAFCLSHQEVATANLAWASVAIHQVQVCRGLAKQTELNDFLLDVSKTYFDNIVAIDSLLEHIMIYAKNLVNADRCALFQVDHKNKELYSDLFDIGEEKEGKPVFKKTKEIRFSIEKGIAGQVARTGEVLNIPDAYADPRFNREVDLYTGYTTRNILCMPIVSRGSVIGVVQMVNKISGSAFSKTDENNFKMFAVFCALALHCANMYHRIRHSECIYRVTMEKLSYHSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED 4DFF,6IJH,4AEL,2WEY,5SKV,5SKU,5SKT,5SKS,5SKR,5SKQ,5SKP,5SKO,5SKN,5SKM,5SKL,5SKK,5SKJ,5SKI,5SKH,5SKG,5SKF,5SKE,5SKD,5SKC,5SKB,5SKA,5SK9,5SK8,5SK7,5SK6,5SK5,5SK4,5SK3,5SK2,5SK1,5SK0,5SJZ,5SJY,5SJX,5SJW,5SJV,5SJU,5SJT,5SJS,5SJR,5SJQ,5SJP,5SJO,5SJN,5SJM,5SJL,5SJK,5SJJ,5SJI,5SJH,5SJG,5SJF,5SJE,5SJD,5SJC,5SJB,5SJA,5SJ9,5SJ8,5SJ7,5SJ6,5SJ5,5SJ4,5SJ3,5SJ2,5SJ1,5SJ0,5SIZ,5SIY,5SIX,5SIW,5SIV,5SIU,5SIT,5SIS,5SIR,5SIQ,5SIP,5SIO,5SIN,5SIM,5SIL,5SIK,5SIJ,5SII,5SIH,5SIG,5SIF,5SIE,5SID,5SIB,5SIA,5SI9,5SI8,5SI7,5SI6,5SI5,5SI4,5SI3,5SI2,5SI1,5SI0,5SHZ,5SHY,5SHX,5SHW,5SHV,5SHU,5SHT,5SHS,5SHR,5SHQ,5SHP,5SHO,5SHN,5SHM,5SHL cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A PDE10_HUMAN Q9Y233 A0A3F2YP58 Q6FHX1 Q9HCP9 Q9NTV4 Q9ULW9 Q9Y5T1 1451655 CNC(=O)Nc1cc(COc2ccc(cc2)-c2nn(C)cc2-c2ccncc2)nc2ccccc12 InChI=1S/C27H24N6O2/c1-28-27(34)31-25-15-20(30-24-6-4-3-5-22(24)25)17-35-21-9-7-19(8-10-21)26-23(16-33(2)32-26)18-11-13-29-14-12-18/h3-16H,17H2,1-2H3,(H2,28,30,31,34) DSBCMABHNGBNFA-UHFFFAOYSA-N 700288 1-Methyl-3-[2-[[4-[1-methyl-4-(4-pyridyl)pyrazol-3-yl]phenoxy]methyl]-4-quinolyl]urea::US20240336591, Example 35 cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A isoform 2 Homo sapiens 0.214 US Patent 10.7270/Q29G5S87 aid2060456 US20240336591 PATIENT, L; ALMOND-THYNNE, J; UNSWORTH, PJ; YIP, AC; ROBAS, N; BELICH, MP 10/10/2024 2/10/2025 Benevolentai Cambridge http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=700288 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8174&target=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A+isoform+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=700288&enzyme=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A+isoform+2&column=ki&startPg=0&Increment=50&submit=Search 167444597 505949358 1 MEDGPSNNASCFRRLTECFLSPSLTDEKVKAYLSLHPQVLDEFVSESVSAETVEKWLKRKNNKSEDESAPKEVSRYQDTNMQGVVYELNSYIEQRLDTGGDNQLLLYELSSIIKIATKADGFALYFLGECNNSLCIFTPPGIKEGKPRLIPAGPITQGTTVSAYVAKSRKTLLVEDILGDERFPRGTGLESGTRIQSVLCLPIVTAIGDLIGILELYRHWGKEAFCLSHQEVATANLAWASVAIHQVQVCRGLAKQTELNDFLLDVSKTYFDNIVAIDSLLEHIMIYAKNLVNADRCALFQVDHKNKELYSDLFDIGEEKEGKPVFKKTKEIRFSIEKGIAGQVARTGEVLNIPDAYADPRFNREVDLYTGYTTRNILCMPIVSRGSVIGVVQMVNKISGSAFSKTDENNFKMFAVFCALALHCANMYHRIRHSECIYRVTMEKLSYHSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED 4DFF,6IJH,4AEL,2WEY,5SKV,5SKU,5SKT,5SKS,5SKR,5SKQ,5SKP,5SKO,5SKN,5SKM,5SKL,5SKK,5SKJ,5SKI,5SKH,5SKG,5SKF,5SKE,5SKD,5SKC,5SKB,5SKA,5SK9,5SK8,5SK7,5SK6,5SK5,5SK4,5SK3,5SK2,5SK1,5SK0,5SJZ,5SJY,5SJX,5SJW,5SJV,5SJU,5SJT,5SJS,5SJR,5SJQ,5SJP,5SJO,5SJN,5SJM,5SJL,5SJK,5SJJ,5SJI,5SJH,5SJG,5SJF,5SJE,5SJD,5SJC,5SJB,5SJA,5SJ9,5SJ8,5SJ7,5SJ6,5SJ5,5SJ4,5SJ3,5SJ2,5SJ1,5SJ0,5SIZ,5SIY,5SIX,5SIW,5SIV,5SIU,5SIT,5SIS,5SIR,5SIQ,5SIP,5SIO,5SIN,5SIM,5SIL,5SIK,5SIJ,5SII,5SIH,5SIG,5SIF,5SIE,5SID,5SIB,5SIA,5SI9,5SI8,5SI7,5SI6,5SI5,5SI4,5SI3,5SI2,5SI1,5SI0,5SHZ,5SHY,5SHX,5SHW,5SHV,5SHU,5SHT,5SHS,5SHR,5SHQ,5SHP,5SHO,5SHN,5SHM,5SHL cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A PDE10_HUMAN Q9Y233 A0A3F2YP58 Q6FHX1 Q9HCP9 Q9NTV4 Q9ULW9 Q9Y5T1 1451656 Cn1cc(c(n1)-c1ccc(OCc2cc(NC(=O)N=S(C)(C)=O)c3ccccc3n2)cc1)-c1ccncc1 InChI=1S/C28H26N6O3S/c1-34-17-24(19-12-14-29-15-13-19)27(32-34)20-8-10-22(11-9-20)37-18-21-16-26(31-28(35)33-38(2,3)36)23-6-4-5-7-25(23)30-21/h4-17H,18H2,1-3H3,(H,30,31,35) NOBXBUPPWCMOJX-UHFFFAOYSA-N 700289 1-[Dimethyl(oxo)-λ6-sulfanylidene]-3-[2-[[4-[1-methyl-4-(4-pyridyl)pyrazol-3-yl]phenoxy]methyl]-4-quinolyl]urea::US20240336591, Example 36 cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A isoform 2 Homo sapiens 0.347 US Patent 10.7270/Q29G5S87 aid2060456 US20240336591 PATIENT, L; ALMOND-THYNNE, J; UNSWORTH, PJ; YIP, AC; ROBAS, N; BELICH, MP 10/10/2024 2/10/2025 Benevolentai Cambridge http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=700289 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8174&target=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A+isoform+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=700289&enzyme=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A+isoform+2&column=ki&startPg=0&Increment=50&submit=Search 171569324 505949359 1 MEDGPSNNASCFRRLTECFLSPSLTDEKVKAYLSLHPQVLDEFVSESVSAETVEKWLKRKNNKSEDESAPKEVSRYQDTNMQGVVYELNSYIEQRLDTGGDNQLLLYELSSIIKIATKADGFALYFLGECNNSLCIFTPPGIKEGKPRLIPAGPITQGTTVSAYVAKSRKTLLVEDILGDERFPRGTGLESGTRIQSVLCLPIVTAIGDLIGILELYRHWGKEAFCLSHQEVATANLAWASVAIHQVQVCRGLAKQTELNDFLLDVSKTYFDNIVAIDSLLEHIMIYAKNLVNADRCALFQVDHKNKELYSDLFDIGEEKEGKPVFKKTKEIRFSIEKGIAGQVARTGEVLNIPDAYADPRFNREVDLYTGYTTRNILCMPIVSRGSVIGVVQMVNKISGSAFSKTDENNFKMFAVFCALALHCANMYHRIRHSECIYRVTMEKLSYHSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED 4DFF,6IJH,4AEL,2WEY,5SKV,5SKU,5SKT,5SKS,5SKR,5SKQ,5SKP,5SKO,5SKN,5SKM,5SKL,5SKK,5SKJ,5SKI,5SKH,5SKG,5SKF,5SKE,5SKD,5SKC,5SKB,5SKA,5SK9,5SK8,5SK7,5SK6,5SK5,5SK4,5SK3,5SK2,5SK1,5SK0,5SJZ,5SJY,5SJX,5SJW,5SJV,5SJU,5SJT,5SJS,5SJR,5SJQ,5SJP,5SJO,5SJN,5SJM,5SJL,5SJK,5SJJ,5SJI,5SJH,5SJG,5SJF,5SJE,5SJD,5SJC,5SJB,5SJA,5SJ9,5SJ8,5SJ7,5SJ6,5SJ5,5SJ4,5SJ3,5SJ2,5SJ1,5SJ0,5SIZ,5SIY,5SIX,5SIW,5SIV,5SIU,5SIT,5SIS,5SIR,5SIQ,5SIP,5SIO,5SIN,5SIM,5SIL,5SIK,5SIJ,5SII,5SIH,5SIG,5SIF,5SIE,5SID,5SIB,5SIA,5SI9,5SI8,5SI7,5SI6,5SI5,5SI4,5SI3,5SI2,5SI1,5SI0,5SHZ,5SHY,5SHX,5SHW,5SHV,5SHU,5SHT,5SHS,5SHR,5SHQ,5SHP,5SHO,5SHN,5SHM,5SHL cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A PDE10_HUMAN Q9Y233 A0A3F2YP58 Q6FHX1 Q9HCP9 Q9NTV4 Q9ULW9 Q9Y5T1 1451657 Cn1cc(c(n1)-c1ccc(OCc2nc(N3CCS(=O)(=O)CC3)c3ccccc3n2)cc1)-c1ccncc1 InChI=1S/C28H26N6O3S/c1-33-18-24(20-10-12-29-13-11-20)27(32-33)21-6-8-22(9-7-21)37-19-26-30-25-5-3-2-4-23(25)28(31-26)34-14-16-38(35,36)17-15-34/h2-13,18H,14-17,19H2,1H3 JCSKNTRSBRMNDB-UHFFFAOYSA-N 700290 4-[2-[[4-[1-Methyl-4-(4-pyridyl)pyrazol-3-yl]phenoxy]methyl]quinazolin-4-yl]-1,4-thiazinane 1,1-dioxide::US20240336591, Example 37 cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A isoform 2 Homo sapiens 0.224 US Patent 10.7270/Q29G5S87 aid2060456 US20240336591 PATIENT, L; ALMOND-THYNNE, J; UNSWORTH, PJ; YIP, AC; ROBAS, N; BELICH, MP 10/10/2024 2/10/2025 Benevolentai Cambridge http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=700290 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8174&target=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A+isoform+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=700290&enzyme=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A+isoform+2&column=ki&startPg=0&Increment=50&submit=Search 169591578 505949360 1 MEDGPSNNASCFRRLTECFLSPSLTDEKVKAYLSLHPQVLDEFVSESVSAETVEKWLKRKNNKSEDESAPKEVSRYQDTNMQGVVYELNSYIEQRLDTGGDNQLLLYELSSIIKIATKADGFALYFLGECNNSLCIFTPPGIKEGKPRLIPAGPITQGTTVSAYVAKSRKTLLVEDILGDERFPRGTGLESGTRIQSVLCLPIVTAIGDLIGILELYRHWGKEAFCLSHQEVATANLAWASVAIHQVQVCRGLAKQTELNDFLLDVSKTYFDNIVAIDSLLEHIMIYAKNLVNADRCALFQVDHKNKELYSDLFDIGEEKEGKPVFKKTKEIRFSIEKGIAGQVARTGEVLNIPDAYADPRFNREVDLYTGYTTRNILCMPIVSRGSVIGVVQMVNKISGSAFSKTDENNFKMFAVFCALALHCANMYHRIRHSECIYRVTMEKLSYHSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED 4DFF,6IJH,4AEL,2WEY,5SKV,5SKU,5SKT,5SKS,5SKR,5SKQ,5SKP,5SKO,5SKN,5SKM,5SKL,5SKK,5SKJ,5SKI,5SKH,5SKG,5SKF,5SKE,5SKD,5SKC,5SKB,5SKA,5SK9,5SK8,5SK7,5SK6,5SK5,5SK4,5SK3,5SK2,5SK1,5SK0,5SJZ,5SJY,5SJX,5SJW,5SJV,5SJU,5SJT,5SJS,5SJR,5SJQ,5SJP,5SJO,5SJN,5SJM,5SJL,5SJK,5SJJ,5SJI,5SJH,5SJG,5SJF,5SJE,5SJD,5SJC,5SJB,5SJA,5SJ9,5SJ8,5SJ7,5SJ6,5SJ5,5SJ4,5SJ3,5SJ2,5SJ1,5SJ0,5SIZ,5SIY,5SIX,5SIW,5SIV,5SIU,5SIT,5SIS,5SIR,5SIQ,5SIP,5SIO,5SIN,5SIM,5SIL,5SIK,5SIJ,5SII,5SIH,5SIG,5SIF,5SIE,5SID,5SIB,5SIA,5SI9,5SI8,5SI7,5SI6,5SI5,5SI4,5SI3,5SI2,5SI1,5SI0,5SHZ,5SHY,5SHX,5SHW,5SHV,5SHU,5SHT,5SHS,5SHR,5SHQ,5SHP,5SHO,5SHN,5SHM,5SHL cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A PDE10_HUMAN Q9Y233 A0A3F2YP58 Q6FHX1 Q9HCP9 Q9NTV4 Q9ULW9 Q9Y5T1 1451658 Cn1cc(c(n1)-c1ccc(OCc2nc(N3CCNC(=O)C3)c3ccccc3n2)cc1)-c1ccncc1 InChI=1S/C28H25N7O2/c1-34-16-23(19-10-12-29-13-11-19)27(33-34)20-6-8-21(9-7-20)37-18-25-31-24-5-3-2-4-22(24)28(32-25)35-15-14-30-26(36)17-35/h2-13,16H,14-15,17-18H2,1H3,(H,30,36) OKTCKPNRZYXMMC-UHFFFAOYSA-N 700291 4-[2-[[4-[1-Methyl-4-(4-pyridyl)pyrazol-3-yl]phenoxy]methyl]quinazolin-4-yl]piperazin-2-one::US20240336591, Example 38 cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A isoform 2 Homo sapiens 0.079 US Patent 10.7270/Q29G5S87 aid2060456 US20240336591 PATIENT, L; ALMOND-THYNNE, J; UNSWORTH, PJ; YIP, AC; ROBAS, N; BELICH, MP 10/10/2024 2/10/2025 Benevolentai Cambridge http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=700291 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8174&target=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A+isoform+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=700291&enzyme=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A+isoform+2&column=ki&startPg=0&Increment=50&submit=Search 167444532 505949361 1 MEDGPSNNASCFRRLTECFLSPSLTDEKVKAYLSLHPQVLDEFVSESVSAETVEKWLKRKNNKSEDESAPKEVSRYQDTNMQGVVYELNSYIEQRLDTGGDNQLLLYELSSIIKIATKADGFALYFLGECNNSLCIFTPPGIKEGKPRLIPAGPITQGTTVSAYVAKSRKTLLVEDILGDERFPRGTGLESGTRIQSVLCLPIVTAIGDLIGILELYRHWGKEAFCLSHQEVATANLAWASVAIHQVQVCRGLAKQTELNDFLLDVSKTYFDNIVAIDSLLEHIMIYAKNLVNADRCALFQVDHKNKELYSDLFDIGEEKEGKPVFKKTKEIRFSIEKGIAGQVARTGEVLNIPDAYADPRFNREVDLYTGYTTRNILCMPIVSRGSVIGVVQMVNKISGSAFSKTDENNFKMFAVFCALALHCANMYHRIRHSECIYRVTMEKLSYHSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED 4DFF,6IJH,4AEL,2WEY,5SKV,5SKU,5SKT,5SKS,5SKR,5SKQ,5SKP,5SKO,5SKN,5SKM,5SKL,5SKK,5SKJ,5SKI,5SKH,5SKG,5SKF,5SKE,5SKD,5SKC,5SKB,5SKA,5SK9,5SK8,5SK7,5SK6,5SK5,5SK4,5SK3,5SK2,5SK1,5SK0,5SJZ,5SJY,5SJX,5SJW,5SJV,5SJU,5SJT,5SJS,5SJR,5SJQ,5SJP,5SJO,5SJN,5SJM,5SJL,5SJK,5SJJ,5SJI,5SJH,5SJG,5SJF,5SJE,5SJD,5SJC,5SJB,5SJA,5SJ9,5SJ8,5SJ7,5SJ6,5SJ5,5SJ4,5SJ3,5SJ2,5SJ1,5SJ0,5SIZ,5SIY,5SIX,5SIW,5SIV,5SIU,5SIT,5SIS,5SIR,5SIQ,5SIP,5SIO,5SIN,5SIM,5SIL,5SIK,5SIJ,5SII,5SIH,5SIG,5SIF,5SIE,5SID,5SIB,5SIA,5SI9,5SI8,5SI7,5SI6,5SI5,5SI4,5SI3,5SI2,5SI1,5SI0,5SHZ,5SHY,5SHX,5SHW,5SHV,5SHU,5SHT,5SHS,5SHR,5SHQ,5SHP,5SHO,5SHN,5SHM,5SHL cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A PDE10_HUMAN Q9Y233 A0A3F2YP58 Q6FHX1 Q9HCP9 Q9NTV4 Q9ULW9 Q9Y5T1 1451659 Cn1cc(c(n1)-c1ccc(OCc2nc(N3CC(N)C3)c3ccccc3n2)cc1)-c1ccncc1 InChI=1S/C27H25N7O/c1-33-16-23(18-10-12-29-13-11-18)26(32-33)19-6-8-21(9-7-19)35-17-25-30-24-5-3-2-4-22(24)27(31-25)34-14-20(28)15-34/h2-13,16,20H,14-15,17,28H2,1H3 CXMOEPNVLBUDHQ-UHFFFAOYSA-N 700292 1-[2-[[4-[1-Methyl-4-(4-pyridyl)pyrazol-3-yl]phenoxy]methyl]quinazolin-4-yl]azetidin-3-amine::US20240336591, Example 39 cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A isoform 2 Homo sapiens 0.347 US Patent 10.7270/Q29G5S87 aid2060456 US20240336591 PATIENT, L; ALMOND-THYNNE, J; UNSWORTH, PJ; YIP, AC; ROBAS, N; BELICH, MP 10/10/2024 2/10/2025 Benevolentai Cambridge http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=700292 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8174&target=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A+isoform+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=700292&enzyme=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A+isoform+2&column=ki&startPg=0&Increment=50&submit=Search 167444573 505949362 1 MEDGPSNNASCFRRLTECFLSPSLTDEKVKAYLSLHPQVLDEFVSESVSAETVEKWLKRKNNKSEDESAPKEVSRYQDTNMQGVVYELNSYIEQRLDTGGDNQLLLYELSSIIKIATKADGFALYFLGECNNSLCIFTPPGIKEGKPRLIPAGPITQGTTVSAYVAKSRKTLLVEDILGDERFPRGTGLESGTRIQSVLCLPIVTAIGDLIGILELYRHWGKEAFCLSHQEVATANLAWASVAIHQVQVCRGLAKQTELNDFLLDVSKTYFDNIVAIDSLLEHIMIYAKNLVNADRCALFQVDHKNKELYSDLFDIGEEKEGKPVFKKTKEIRFSIEKGIAGQVARTGEVLNIPDAYADPRFNREVDLYTGYTTRNILCMPIVSRGSVIGVVQMVNKISGSAFSKTDENNFKMFAVFCALALHCANMYHRIRHSECIYRVTMEKLSYHSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED 4DFF,6IJH,4AEL,2WEY,5SKV,5SKU,5SKT,5SKS,5SKR,5SKQ,5SKP,5SKO,5SKN,5SKM,5SKL,5SKK,5SKJ,5SKI,5SKH,5SKG,5SKF,5SKE,5SKD,5SKC,5SKB,5SKA,5SK9,5SK8,5SK7,5SK6,5SK5,5SK4,5SK3,5SK2,5SK1,5SK0,5SJZ,5SJY,5SJX,5SJW,5SJV,5SJU,5SJT,5SJS,5SJR,5SJQ,5SJP,5SJO,5SJN,5SJM,5SJL,5SJK,5SJJ,5SJI,5SJH,5SJG,5SJF,5SJE,5SJD,5SJC,5SJB,5SJA,5SJ9,5SJ8,5SJ7,5SJ6,5SJ5,5SJ4,5SJ3,5SJ2,5SJ1,5SJ0,5SIZ,5SIY,5SIX,5SIW,5SIV,5SIU,5SIT,5SIS,5SIR,5SIQ,5SIP,5SIO,5SIN,5SIM,5SIL,5SIK,5SIJ,5SII,5SIH,5SIG,5SIF,5SIE,5SID,5SIB,5SIA,5SI9,5SI8,5SI7,5SI6,5SI5,5SI4,5SI3,5SI2,5SI1,5SI0,5SHZ,5SHY,5SHX,5SHW,5SHV,5SHU,5SHT,5SHS,5SHR,5SHQ,5SHP,5SHO,5SHN,5SHM,5SHL cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A PDE10_HUMAN Q9Y233 A0A3F2YP58 Q6FHX1 Q9HCP9 Q9NTV4 Q9ULW9 Q9Y5T1 1451660 Cn1cc(c(n1)-c1ccc(OCc2nc(N3CCNCC3)c3ccccc3n2)cc1)-c1ccncc1 InChI=1S/C28H27N7O/c1-34-18-24(20-10-12-29-13-11-20)27(33-34)21-6-8-22(9-7-21)36-19-26-31-25-5-3-2-4-23(25)28(32-26)35-16-14-30-15-17-35/h2-13,18,30H,14-17,19H2,1H3 ZYKLPQIWINNBID-UHFFFAOYSA-N 700293 2-[[4-[1-Methyl-4-(4- pyridyl)pyrazol-3- yl]phenoxy]methyl]- 4-piperazin-1-yl- quinazoline::US20240336591, Example 40 cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A isoform 2 Homo sapiens 1.05 US Patent 10.7270/Q29G5S87 aid2060456 US20240336591 PATIENT, L; ALMOND-THYNNE, J; UNSWORTH, PJ; YIP, AC; ROBAS, N; BELICH, MP 10/10/2024 2/10/2025 Benevolentai Cambridge http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=700293 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8174&target=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A+isoform+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=700293&enzyme=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A+isoform+2&column=ki&startPg=0&Increment=50&submit=Search 167444562 505949363 1 MEDGPSNNASCFRRLTECFLSPSLTDEKVKAYLSLHPQVLDEFVSESVSAETVEKWLKRKNNKSEDESAPKEVSRYQDTNMQGVVYELNSYIEQRLDTGGDNQLLLYELSSIIKIATKADGFALYFLGECNNSLCIFTPPGIKEGKPRLIPAGPITQGTTVSAYVAKSRKTLLVEDILGDERFPRGTGLESGTRIQSVLCLPIVTAIGDLIGILELYRHWGKEAFCLSHQEVATANLAWASVAIHQVQVCRGLAKQTELNDFLLDVSKTYFDNIVAIDSLLEHIMIYAKNLVNADRCALFQVDHKNKELYSDLFDIGEEKEGKPVFKKTKEIRFSIEKGIAGQVARTGEVLNIPDAYADPRFNREVDLYTGYTTRNILCMPIVSRGSVIGVVQMVNKISGSAFSKTDENNFKMFAVFCALALHCANMYHRIRHSECIYRVTMEKLSYHSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED 4DFF,6IJH,4AEL,2WEY,5SKV,5SKU,5SKT,5SKS,5SKR,5SKQ,5SKP,5SKO,5SKN,5SKM,5SKL,5SKK,5SKJ,5SKI,5SKH,5SKG,5SKF,5SKE,5SKD,5SKC,5SKB,5SKA,5SK9,5SK8,5SK7,5SK6,5SK5,5SK4,5SK3,5SK2,5SK1,5SK0,5SJZ,5SJY,5SJX,5SJW,5SJV,5SJU,5SJT,5SJS,5SJR,5SJQ,5SJP,5SJO,5SJN,5SJM,5SJL,5SJK,5SJJ,5SJI,5SJH,5SJG,5SJF,5SJE,5SJD,5SJC,5SJB,5SJA,5SJ9,5SJ8,5SJ7,5SJ6,5SJ5,5SJ4,5SJ3,5SJ2,5SJ1,5SJ0,5SIZ,5SIY,5SIX,5SIW,5SIV,5SIU,5SIT,5SIS,5SIR,5SIQ,5SIP,5SIO,5SIN,5SIM,5SIL,5SIK,5SIJ,5SII,5SIH,5SIG,5SIF,5SIE,5SID,5SIB,5SIA,5SI9,5SI8,5SI7,5SI6,5SI5,5SI4,5SI3,5SI2,5SI1,5SI0,5SHZ,5SHY,5SHX,5SHW,5SHV,5SHU,5SHT,5SHS,5SHR,5SHQ,5SHP,5SHO,5SHN,5SHM,5SHL cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A PDE10_HUMAN Q9Y233 A0A3F2YP58 Q6FHX1 Q9HCP9 Q9NTV4 Q9ULW9 Q9Y5T1 1451661 Cn1cc(c(n1)-c1ccc(OCc2nc3ccccc3nc2N2CC(N)C2)cc1)-c1ccncc1 InChI=1S/C27H25N7O/c1-33-16-22(18-10-12-29-13-11-18)26(32-33)19-6-8-21(9-7-19)35-17-25-27(34-14-20(28)15-34)31-24-5-3-2-4-23(24)30-25/h2-13,16,20H,14-15,17,28H2,1H3 ULVXOIHWENEPDX-UHFFFAOYSA-N 700294 1-[3-[[4-[1-Methyl-4- (4-pyridyl)pyrazol- 3- yl]phenoxy]methyl] quinoxalin-2- yl]azetidin-3-amine::US20240336591, Example 41 cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A isoform 2 Homo sapiens 0.355 US Patent 10.7270/Q29G5S87 aid2060456 US20240336591 PATIENT, L; ALMOND-THYNNE, J; UNSWORTH, PJ; YIP, AC; ROBAS, N; BELICH, MP 10/10/2024 2/10/2025 Benevolentai Cambridge http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=700294 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8174&target=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A+isoform+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=700294&enzyme=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A+isoform+2&column=ki&startPg=0&Increment=50&submit=Search 167444583 505949364 1 MEDGPSNNASCFRRLTECFLSPSLTDEKVKAYLSLHPQVLDEFVSESVSAETVEKWLKRKNNKSEDESAPKEVSRYQDTNMQGVVYELNSYIEQRLDTGGDNQLLLYELSSIIKIATKADGFALYFLGECNNSLCIFTPPGIKEGKPRLIPAGPITQGTTVSAYVAKSRKTLLVEDILGDERFPRGTGLESGTRIQSVLCLPIVTAIGDLIGILELYRHWGKEAFCLSHQEVATANLAWASVAIHQVQVCRGLAKQTELNDFLLDVSKTYFDNIVAIDSLLEHIMIYAKNLVNADRCALFQVDHKNKELYSDLFDIGEEKEGKPVFKKTKEIRFSIEKGIAGQVARTGEVLNIPDAYADPRFNREVDLYTGYTTRNILCMPIVSRGSVIGVVQMVNKISGSAFSKTDENNFKMFAVFCALALHCANMYHRIRHSECIYRVTMEKLSYHSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED 4DFF,6IJH,4AEL,2WEY,5SKV,5SKU,5SKT,5SKS,5SKR,5SKQ,5SKP,5SKO,5SKN,5SKM,5SKL,5SKK,5SKJ,5SKI,5SKH,5SKG,5SKF,5SKE,5SKD,5SKC,5SKB,5SKA,5SK9,5SK8,5SK7,5SK6,5SK5,5SK4,5SK3,5SK2,5SK1,5SK0,5SJZ,5SJY,5SJX,5SJW,5SJV,5SJU,5SJT,5SJS,5SJR,5SJQ,5SJP,5SJO,5SJN,5SJM,5SJL,5SJK,5SJJ,5SJI,5SJH,5SJG,5SJF,5SJE,5SJD,5SJC,5SJB,5SJA,5SJ9,5SJ8,5SJ7,5SJ6,5SJ5,5SJ4,5SJ3,5SJ2,5SJ1,5SJ0,5SIZ,5SIY,5SIX,5SIW,5SIV,5SIU,5SIT,5SIS,5SIR,5SIQ,5SIP,5SIO,5SIN,5SIM,5SIL,5SIK,5SIJ,5SII,5SIH,5SIG,5SIF,5SIE,5SID,5SIB,5SIA,5SI9,5SI8,5SI7,5SI6,5SI5,5SI4,5SI3,5SI2,5SI1,5SI0,5SHZ,5SHY,5SHX,5SHW,5SHV,5SHU,5SHT,5SHS,5SHR,5SHQ,5SHP,5SHO,5SHN,5SHM,5SHL cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A PDE10_HUMAN Q9Y233 A0A3F2YP58 Q6FHX1 Q9HCP9 Q9NTV4 Q9ULW9 Q9Y5T1 1451662 Cn1cc(c(n1)-c1ccc(OCc2nc3ccccc3nc2N2CCNCC2)cc1)-c1ccncc1 InChI=1S/C28H27N7O/c1-34-18-23(20-10-12-29-13-11-20)27(33-34)21-6-8-22(9-7-21)36-19-26-28(35-16-14-30-15-17-35)32-25-5-3-2-4-24(25)31-26/h2-13,18,30H,14-17,19H2,1H3 OQDJLZDLUGZQQP-UHFFFAOYSA-N 700295 2-[[4-[1-Methyl-4-(4- pyridyl)pyrazol-3- yl]phenoxy]methyl]- 3-piperazin-1-yl- quinoxaline::US20240336591, Example 42 cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A isoform 2 Homo sapiens 1.10 US Patent 10.7270/Q29G5S87 aid2060456 US20240336591 PATIENT, L; ALMOND-THYNNE, J; UNSWORTH, PJ; YIP, AC; ROBAS, N; BELICH, MP 10/10/2024 2/10/2025 Benevolentai Cambridge http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=700295 http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=8174&target=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A+isoform+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=700295&enzyme=cAMP+and+cAMP-inhibited+cGMP+3%27%2C5%27-cyclic+phosphodiesterase+10A+isoform+2&column=ki&startPg=0&Increment=50&submit=Search 169591607 505949365 1 MEDGPSNNASCFRRLTECFLSPSLTDEKVKAYLSLHPQVLDEFVSESVSAETVEKWLKRKNNKSEDESAPKEVSRYQDTNMQGVVYELNSYIEQRLDTGGDNQLLLYELSSIIKIATKADGFALYFLGECNNSLCIFTPPGIKEGKPRLIPAGPITQGTTVSAYVAKSRKTLLVEDILGDERFPRGTGLESGTRIQSVLCLPIVTAIGDLIGILELYRHWGKEAFCLSHQEVATANLAWASVAIHQVQVCRGLAKQTELNDFLLDVSKTYFDNIVAIDSLLEHIMIYAKNLVNADRCALFQVDHKNKELYSDLFDIGEEKEGKPVFKKTKEIRFSIEKGIAGQVARTGEVLNIPDAYADPRFNREVDLYTGYTTRNILCMPIVSRGSVIGVVQMVNKISGSAFSKTDENNFKMFAVFCALALHCANMYHRIRHSECIYRVTMEKLSYHSICTSEEWQGLMQFTLPVRLCKEIELFHFDIGPFENMWPGIFVYMVHRSCGTSCFELEKLCRFIMSVKKNYRRVPYHNWKHAVTVAHCMYAILQNNHTLFTDLERKGLLIACLCHDLDHRGFSNSYLQKFDHPLAALYSTSTMEQHHFSQTVSILQLEGHNIFSTLSSSEYEQVLEIIRKAIIATDLALYFGNRKQLEEMYQTGSLNLNNQSHRDRVIGLMMTACDLCSVTKLWPVTKLTANDIYAEFWAEGDEMKKLGIQPIPMMDRDKKDEVPQGQLGFYNAVAIPCYTTLTQILPPTEPLLKACRDNLSQWEKVIRGEETATWISSPSVAQKAAASED 4DFF,6IJH,4AEL,2WEY,5SKV,5SKU,5SKT,5SKS,5SKR,5SKQ,5SKP,5SKO,5SKN,5SKM,5SKL,5SKK,5SKJ,5SKI,5SKH,5SKG,5SKF,5SKE,5SKD,5SKC,5SKB,5SKA,5SK9,5SK8,5SK7,5SK6,5SK5,5SK4,5SK3,5SK2,5SK1,5SK0,5SJZ,5SJY,5SJX,5SJW,5SJV,5SJU,5SJT,5SJS,5SJR,5SJQ,5SJP,5SJO,5SJN,5SJM,5SJL,5SJK,5SJJ,5SJI,5SJH,5SJG,5SJF,5SJE,5SJD,5SJC,5SJB,5SJA,5SJ9,5SJ8,5SJ7,5SJ6,5SJ5,5SJ4,5SJ3,5SJ2,5SJ1,5SJ0,5SIZ,5SIY,5SIX,5SIW,5SIV,5SIU,5SIT,5SIS,5SIR,5SIQ,5SIP,5SIO,5SIN,5SIM,5SIL,5SIK,5SIJ,5SII,5SIH,5SIG,5SIF,5SIE,5SID,5SIB,5SIA,5SI9,5SI8,5SI7,5SI6,5SI5,5SI4,5SI3,5SI2,5SI1,5SI0,5SHZ,5SHY,5SHX,5SHW,5SHV,5SHU,5SHT,5SHS,5SHR,5SHQ,5SHP,5SHO,5SHN,5SHM,5SHL cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A PDE10_HUMAN Q9Y233 A0A3F2YP58 Q6FHX1 Q9HCP9 Q9NTV4 Q9ULW9 Q9Y5T1